mutationType,diseaseName,Phenotype,GenBankaccessionnumber,gene,Locus,mutationSite,originalCodon,mutatedCodon,chromosome,Genomeposition,denovoinherited,zygosity,incidenceRate,DiagnosticMethod,References,source,
nonsense,Osteogenesis imperfecta,610682,NM_006371.5,CRTAP,605497,c.241G>T,GAG，p.Glu81,TAG，stop codon,3p22.3,chr3:33114318 (hg38),inherited,heterozygous,N/A,ventriculosubgaleal shunt placement ,http://dx.doi.org/10.1038/s41439-024-00274-z,https://hgv.figshare.com/genome_variation/3385,,
nonsense,Common variable immunodeficiency,616576,NM_003998.4,NFKB1,164011,c.136C>T,CAA，p.Gln46,TAA，stop codon,4q24,chr4:102533862,de novo,heterozygous,"4%（NFKB1 as the most common causative gene of CVID, accounting for 4% of CVID cases in a predominantly European population）",genetic testing ,http://dx.doi.org/10.1038/s41439-024-00271-2,https://hgv.figshare.com/genome_variation/3379,,
nonsense,Recessive dystrophic epidermolysis bullosa (RDEB),226600,NM_000094.4,COL7A1,120120,c.793C>T,CAG，p.Gln265,TAG，stop codon,3p21.31,48592828,inherited,homozygous,N/A,the combination of long PCR-based NGS and SNP arrays enables rapid and accurate genetic diagnosis,http://dx.doi.org/10.1038/s41439-023-00257-6,https://hgv.figshare.com/genome_variation/3334,,
nonsense,Centronuclear myopathy (CNM),615959,NM_005876.5,SPEG,615950,c.5343G>A,TGG，p.Trp1781,TGA，stop codon,2q35,220345393,inherited,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/s41439-023-00253-w,https://hgv.figshare.com/genome_variation/3324,,
nonsense,Developmental and epileptic encephalopathy (DEE),N/A,NM_016121,KCTD3,613272,c.1192C>T,CGA，p.Arg398,TGA，stop codon,1q41,215777527(GRCh37/hg19),inherited,homozygous,N/A,molecular diagnosis,http://dx.doi.org/10.1038/s41439-023-00250-z,https://hgv.figshare.com/genome_variation/3312,,
nonsense,X-linked intellectual disability (XLID),300982,NM_030624.3,KLHL15,300980,c.736C>T,CGA，p.Arg246,TGA，stop codon,Xp22.1,23989001,inherited,hemizygous,0.05-0.3%（ID occurs in ~1–3% of the population worldwide1. X-linked ID (XLID) accounts for 5–10% of all types of ID and is the most common cause of ID in males）,various clinical manifestations,http://dx.doi.org/10.1038/s41439-023-00248-7,https://hgv.figshare.com/genome_variation/3308,,
nonsense,Nonsyndromic oligodontia,150400,NM_025216.3,WNT10A,606268,c.1090A>T,AAG，p.Lys364,TAG，stop codon,2q35,219757829,de novo,heterozygous,0.1%（0.1% (95% confidence interval: 0.04–0.3%) for oligodontia in the Japanese population）,genetic testing,http://dx.doi.org/10.1038/s41439-023-00230-3,https://hgv.figshare.com/genome_variation/3273,,
nonsense,Alport syndrome (AS),301050,NM_033380.3,COL4A5,303630,c.2636C>A,TCA，p.Ser879,TAA，stop codon,Xq22.3,107863615,inherited,heterozygous,"1/2,320 (Predicted pathogenic COL4A5 variants are estimated to be present in at least 1 in 2320 individuals, although the exact prevalence of X-linked Alport syndrome is unknown)",clinical next-generation sequencing,http://dx.doi.org/10.1038/s41439-023-00233-0,https://hgv.figshare.com/genome_variation/3267,,
nonsense,"Deafness, autosomal recessive 102 (DFNB102)",615974,NM_004447,EPS8,600206,c.1259G>A,TGG，p.Trp420,TAG，stop codon,12p12.3,15650998,inherited,homozygous,N/A,clinical characteristics,http://dx.doi.org/10.1038/s41439-023-00229-w,https://hgv.figshare.com/genome_variation/3264,,
nonsense,Lynch syndrome,614350,NM_000179.2,MSH6,600678,c.484G>T,GGA，p.Gly162,TGA，stop codon,2p16.3,48023059 (GRCh37.p13),inherited,heterozygous,N/A,visual invasive examinations,http://dx.doi.org/10.1038/s41439-022-00216-7,https://hgv.figshare.com/genome_variation/3243,,
nonsense,Myoclonic dystonia (DYT),159900,NM_003919.3,SGCE,604149,c.304C>T,CGA，p.Arg102,TGA，stop codon,7q21.3,94257600,inherited,heterozygous,N/A,molecular diagnosis,http://dx.doi.org/10.1038/s41439-022-00207-8,https://hgv.figshare.com/genome_variation/3213,,
nonsense,Ankyloblepharon-ectodermal defect–cleft lip/palate syndrome and Rapp–Hodgkin syndrome,106260,NM_001114980.2,TP63,603273,c.25C>T,CAG，p.Gln9,TAG，stop codon,3q28,189507614(GRCh37),de novo / inherited,heterozygous,N/A,genetic testing,http://dx.doi.org/10.1038/s41439-022-00186-w,https://hgv.figshare.com/genome_variation/3119,,
nonsense,Retinitis pigmentosa 2(RP2)-associated retinal disorder,312600,NM_006915.3,RP2,312600,c.358C>T,CGA，p.Arg120,TGA，stop codon,Xp11.3,46713166 (hg19),inherited,hemizygous,1.4%（RP2-RD accounts for 1.4% of Japanese patients with inherited retinal disease）,adeno-associated virus-mediated gene augmentation rescued the degeneration of RP2-knockout organoids by facilitating morphological preservation and improved rhodopsin expression,http://dx.doi.org/10.1038/s41439-021-00178-2,https://hgv.figshare.com/genome_variation/3113,,
nonsense,Neurodevelopmental disorder with absent language and variable seizures,618707,NM_003931.3,WASF1,605035,c.1516C>T,CGA，p.Arg506,TGA，stop codon,6q21,110422797 (hg19),de novo,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/s41439-021-00176-4,https://hgv.figshare.com/genome_variation/3109,,
nonsense,Warburg micro syndrome 1,600118,NM_001172435.2,RAB3GAP1,602536,c.1471C>T,CGA，p.Arg491,TGA，stop codon,2q21.3,135891575,inherited,homozygous,N/A,molecular diagnosis,http://dx.doi.org/10.1038/s41439-021-00171-9,https://hgv.figshare.com/genome_variation/3100,,
nonsense,Warburg micro syndrome 2,600118,NM_001172435.2,RAB3GAP1,602536,c.1552C>T,CAA，p.Gln518,TAA，stop codon,2q21.3,135892887,inherited,homozygous,N/A,molecular diagnosis,http://dx.doi.org/10.1038/s41439-021-00171-9,https://hgv.figshare.com/genome_variation/3097,,
nonsense,Treacher Collins syndrome,154500,NM_001135243.2,TCOF1,606847,c.4111G>T,GAA，p.Glu1371,TAA，stop codon,5q32-q33.1,150396611,de novo,heterozygous,N/A,molecular diagnosis，whole-exome sequencing,http://dx.doi.org/10.1038/s41439-021-00168-4,https://hgv.figshare.com/genome_variation/3092,,
nonsense,Treacher Collins syndrome,154500,NM_001135243.2,TCOF1,606847,c. 2575C>T,CAG，p.Gln859,TAG，stop codon,5q32-q33.1,150379325,de novo,heterozygous,N/A,molecular diagnosis，whole-exome sequencing,http://dx.doi.org/10.1038/s41439-021-00168-4,https://hgv.figshare.com/genome_variation/3089,,
nonsense,Androgen insensitivity syndrome,300068,NM_000044.6,AR,313700,c.1621G>T,GAG，p.Glu541,TAG，stop codon,Xq11-q12,66863102 (GRCh37/hg19),de novo,hemizygous,"1/20,400-1/99,100（The prevalence of AIS is estimated to range from 1/20,400 to 1/99,100 males）",molecular investigation,http://dx.doi.org/10.1038/s41439-021-00167-5,https://hgv.figshare.com/genome_variation/3084,,
nonsense,Intellectual disability and microcephaly,616579,NM_001164144.2,CHAMP1,616327,c.1465C>T,CAG，p.Gln489,TAG，stop codon,13q34,114325307,de novo,heterozygous,N/A,angelman syndrome and Prader-Willi syndrome are the most important differential diagnoses,http://dx.doi.org/10.1038/s41439-021-00165-7,https://hgv.figshare.com/genome_variation/3081,,
nonsense,"Mental retardation, autosomal dominant 7",614104,NM_001396.4,DYRK1A,600855,c.957C>G,TAC，p.Tyr319,TAG，stop codon,21q22.13,"38865324(GRCh37/hg19), 37493022 (GRCh38/hg38)",de novo,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.10.1038/s41439-021-00157-7,https://hgv.figshare.com/genome_variation/3033,,
nonsense,Severe neurodevelopmental delay and frequent vomiting,617865,NM_020928.2,ZSWIM6,615951,c.2737C>T,CGA，p.Arg913,TGA，stop codon,5q12.1,chr5:60837744 (GRCh37),de novo,heterozygous,N/A,we are currently considering the placement of an elemental diet tube into the duodenum to avoid vomiting,http://dx.doi.org/10.1038/s41439-021-00148-8,https://hgv.figshare.com/genome_variation/2999,,
nonsense,Leber congenital amaurosis,6070000000,NM_015120,ALMS1,606844,c.1906G>T,GAG，p.Glu636,TAG，stop codon,2p13.1,73675557,inherited,homozygous,N/A,"annual monitoring of the cardiac, hepatic, and renal phenotypes of such patients will be helpful for differential diagnosis, early treatment, better disease management, and rehabilitation of future cases.",http://dx.doi.org/10.1038/s41439-021-00143-z,https://hgv.figshare.com/genome_variation/2975,,
nonsense,Congenital lypoid adrenal hyperplasia,201710,NM_000349.3,STAR,600617,c.634C>T,CAG，p.Gln212,TAG，stop codon,8q11.23,38145979,uncertain,heterozygous,N/A,genetic testing,http://dx.doi.org/10.1038/s41439-021-00138-w,https://hgv.figshare.com/genome_variation/2966,,
nonsense,Sitosterolemia,210250,NM_022437.3,ABCG8,605460,c.225G>A,TGG，p.Trp75,TGA，stop codon,2p21,44073353 (hg19),inherited,heterozygous,N/A,"in sitosterolemia, prognosis can be improved by proper management, such as restriction of plant sterol intake and administration of a cholesterol absorption inhibitor. ABCG8 genes will play a crucial role in the accurate and early diagnosis of sitosterolemia",http://dx.doi.org/10.1038/s41439-020-00112-y,https://hgv.figshare.com/genome_variation/2897,,
nonsense,Congenital anomalies,N/A,NM_001042749.2,STAG2,300826,c.2229G>A,TGG，p.Trp743,TGA，stop codon,Xq25,123200250,de novo,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/s41439-020-00114-w,https://hgv.figshare.com/genome_variation/2894,,
nonsense,Congenital anomalies,301043,NM_001042749.2,STAG2,300826,c.3097C>T,CGA，p.Arg1033,TGA，stop codon,Xq25,123220440,de novo,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/s41439-020-00114-w,https://hgv.figshare.com/genome_variation/2891,,
nonsense,Fraser syndrome 2,617666,NM_207361.5,FREM2,608945,c.6203T>A,TTA，p.Leu2068,TAA，stop codon,13,chr13:39422631(GRCh37),inherited,heterozygous,"0.43/100,000 (newborns)、11.06/100,000(stillborns)（The prevalence of FS is 0.43 per 100,000 and 11.06 per 100,000 among newborns and stillborns, respectively）",genetic analyses,http://dx.doi.org/10.1038/s41439-020-00119-5,https://hgv.figshare.com/genome_variation/2885,,
nonsense,Primary microcephaly (MCPH),608393,NM_018451.5:,CENPJ,609279,c.1132C>T,CGT，p.Arg378,TGT，stop codon,13q12.12,25481044,uncertain,heterozygous,"0.012%（His mother is a c.289dupA carrier, and his father is a c.1132 C > T carrier. Both mutations were found in the gnomAD browser with frequencies of 0.014% and 0.012%, respectively, in the Latino population.）",NGS studies,http://dx.doi.org/10.1038/s41439-020-0105-3,https://hgv.figshare.com/genome_variation/2861,,
nonsense,Limb-girdle muscular dystrophy type 2I,607155,NM_001039885.2,FKRP,606596,c.692G>A,TGG，p.Trp231,TAG，stop codon,19q13.32,46756142,inherited,heterozygous,"4.3/1,000,000（The prevalence of dystrophinopathy (DMD and Becker-type muscular dystrophy) has been reported5 to be ~2 per 10,000, whereas the prevalence of LGMD2I is 4.3 per million）",FKRP gene analysis,http://dx.doi.org/10.1038/s41439-020-0099-x,https://hgv.figshare.com/genome_variation/2835,,
nonsense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.837C>T,CGA，p.Arg255,TAG，stop codon,Xq28,153296516,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2771,,
nonsense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.808C>T,none，p.Arg270,none，stop codon,Xq28,153296471,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2756,,
nonsense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.880C>T,none，p.Arg294,none，stop codon,Xq28,153296399,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2753,,
nonsense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.502C>T,CGA，p.Arg168,TGA，stop codon,Xq28,153296777,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2741,,
nonsense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.667A>T,none，p.Lys223,none，stop codon,Xq28,153296612,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2732,,
nonsense,X-linked intellectual disability (XLID),300919,NM_001039590.2,USP9X,300072,c.1201C>T,CGA，p.Arg401,TGA，stop codon,Xp11.4,41002583,de novo,hemizygous,0.05-0.3%（ID occurs in ~1–3% of the population worldwide1. X-linked ID (XLID) accounts for 5–10% of all types of ID and is the most common cause of ID in males）,genetic analyses,http://dx.doi.org/10.1038/s41439-019-0081-7,https://hgv.figshare.com/genome_variation/2624,,
nonsense,NTHL1-associated polyposis (NAP),616415,NM_002528,NTHL1,602656,c.268C>T,CAG，p.Gln90,TAG，stop codon,16p13.3,2096239,inherited,homozygous,"0.35%（c.268C>T is the most frequent loss-of-function variant in NTHL1,  with the highest frequency in the European Finnish population (0.35%)）",genetic analyses,http://dx.doi.org/10.1038/s41439-019-0077-3,https://hgv.figshare.com/genome_variation/2606,,
nonsense,Cornelia de Lange syndrome (CdLS),300590,NM_006306,SMC1A,300040,c.1495C>T,CGA，p.Arg499,TGA，stop codon,Xp11.22,53409112 (on Assembly GRCh38),de novo / inherited,heterozygous,30%（the incidence of CHD in patients with CdLS is ~30%）,clinical symptoms caused by dumping syndrome,http://dx.doi.org/10.1038/s41439-019-0053-y,https://hgv.figshare.com/genome_variation/2570,,
nonsense,Neurofibromatosis type 1 (NF1) ,300749,NM_003688,CASK,300172,c.2041C>T,CGA，p.Arg681,TGA，stop codon,Xp11.4,41542805(GRCh38),de novo,heterozygous,N/A,multilocus molecular diagnoses,http://dx.doi.org/10.1038/s41439-019-0051-0,https://hgv.figshare.com/genome_variation/2567,,
nonsense,Basal cell nevus syndrome (BCNS),109400,NM_000264.4,PTCH1,601309,c.1111C>T,CAA，p.Gln371,TAA，stop codon,9q22.32,95479104 (GRCh38),de novo,heterozygous,"1/235,800（the prevalence of BCNS has been reported to be approximately 1 per 235,800 in the Japanese population, with an equal frequency in males and females）",enucleation of KCOTs；orthodontic treatment,http://dx.doi.org/10.1038/s41439-019-0047-9,https://hgv.figshare.com/genome_variation/2546,,
nonsense,Hypomagnesemia 1(HOMG1),602014,NM_017662.5,TRPM6,607009,c.1483C>T,CAA，p.Gln495,TAA，stop codon,9q21.13,77425745,inherited,heterozygous,N/A,magnesium administration,http://dx.doi.org/10.1038/s41439-019-0043-0,https://hgv.figshare.com/genome_variation/2540,,
nonsense,Bardet–Biedl syndrome (BBS),615985,NM_001288781.1,TTC8,608132,c.226C>T,CAA，p.Gln76,TAA，stop codon,14?1.3,89305907(GRCh37.p13),inherited,heterozygous,2.8%（BBS patients with mutations in the TTC8 gene comprise only 2.8% of all BSS patients）,whole-exome sequencing (WES),http://dx.doi.org/10.1038/s41439-019-0045-y,https://hgv.figshare.com/genome_variation/2528,,
nonsense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.267T>A,TAT，p.Tyr89,TAA，stop codon,Xp22.2-p22.1,18665370,inherited,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2435,,
nonsense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.98G>A,TGG，p.Trp33,TAG，stop codon,Xp22.2-p22.1,18674859,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2417,,
nonsense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.49G>T,GAA，p.Glu17,TAA，stop codon,Xp22.2-p22.1,18690140,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2411,,
nonsense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.330T>A,TGT，p.Cys110,TGA，stop codon,Xp22.2-p22.1,18662742,inherited,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2453,,
nonsense,Pallister-Hall syndrome,146510,NM_000168.5,GLI3,165240,c.2071C>T,CAG，p.Gln691,TAG，stop codon,7p14.1,42011968 (GRCh37),de novo,heterozygous,N/A,molecular testing of the GLI3 zinc finger transcription factor gene on 7p14.1,https://www.nature.com/articles/s41439-018-0031-9,https://hgv.figshare.com/genome_variation/2402,,
nonsense,3M Syndrome,273750,NM_014780.4,CUL7,273750,c.203G>A,TGG，p.Trp68,TAG，stop codon,6p21.1,43052586,inherited,heterozygous,CUL7 mutation is found in 65% of 3M syndrome patients,targeted next-generation sequencing,http://dx.doi.org/10.1038/s41439-018-0029-3,https://hgv.figshare.com/genome_variation/2372,,
nonsense,Sensorineural hearing loss,601316,NM_004100.4,EYA4,603550,c.1177C>T,CAG，p.Gln393,TAG，stop codon,6q23.2,133804239,inherited,heterozygous,N/A,next-generation sequencing,http://dx.doi.org/10.1038/s41439-018-0023-9,https://hgv.figshare.com/genome_variation/2366,,
nonsense,Ectodermal dysplasias (EDs),616069,NM_005228,EGFR,131550,c.292C>T,CGA，p.Arg98,TGA，stop codon,7p11.2,55211049,inherited,heterozygous,N/A,patients with biallelic mutations of EGFR can be diagnosed with ED,http://dx.doi.org/10.1038/s41439-018-0011-0,https://hgv.figshare.com/genome_variation/2309,,
nonsense,Spastic paraplegia and psychomotor retardation with or without seizures (SPPRS),616756,NM_020771.3,HACE1,610876,c.1110G>A,TGG，p.Trp370,TGA，stop codon,6q16.3,105233159,inherited,homozygous,the case reported here is the 15th case worldwide,genetic analyses,http://dx.doi.org/10.1038/hgv.2017.61,https://hgv.figshare.com/genome_variation/1744,,
nonsense,Bardet–Biedl syndrome (BBS),615987,NM_024685.3,BBS10,610148,c.1974T>G,TAT，p.Tyr658,TAG，stop codon,12q21.2,76344485,inherited,heterozygous,21 mutations in BBS genes have been reported in patients with BBS,whole-exome sequencing,http://dx.doi.org/10.1038/hgv.2017.33,https://hgv.figshare.com/genome_variation/1390,,
nonsense,Bardet–Biedl syndrome (BBS),615687,NM_024685.3,BBS10,610148,c.1677C>A,TAC，p.Tyr559,TAA，stop codon,12q21.2,76344485,inherited,heterozygous,21 mutations in BBS genes have been reported in patients with BBS,whole-exome sequencing,http://dx.doi.org/10.1038/hgv.2017.33,https://hgv.figshare.com/genome_variation/1387,,
nonsense,Waardenburg syndrome (WS),193500,NG_011632.1,PAX3,606597,c.598C>T,CAA，p.Gln200,TAA，stop codon,2,223096991,inherited,heterozygous,"1/42,000（an estimated prevalence of 1:42,000）",whole-exome sequencing (WES),http://dx.doi.org/10.1038/hgv.2017.27,https://hgv.figshare.com/genome_variation/1370,,
nonsense,Fazio–Londe syndrome,211500,NM_033409,SLC52A3,613350,c.71G>A,TGG，p.Trp24,TAG，stop codon,20p13,"20:760,079-775,984",inherited,homozygous,only 74 cases have been reported worldwide,supplementation of riboflavin is a lifesaving treatment for a number of young patients；prenatal diagnosis,http://dx.doi.org/10.1038/hgv.2017.18,https://hgv.figshare.com/genome_variation/1354,,
nonsense,Cabezas syndrome,300354,NM_003588.3,CUL4B,300304,c.2698G>T,GAA，p.Glu900,TAA，stop codon,Xq24,119660660,inherited,homozygous,N/A,molecular diagnosis by this genome-first approach using targeted high-throughput NGS ,http://dx.doi.org/10.1038/hgv.2016.45,https://hgv.figshare.com/genome_variation/912,,
nonsense,Autosomal recessive retinitis pigmentosa (RP),613810,NM_000440.2,PDE6a,180071,c.769C>T,CGA，p.Arg257,TGA，stop codon,5q,"chr5:149,857,956-149,944,793",inherited,homozygous,"1/4,000（Though it affects one in 4,000, RP is clinically variable）",clinical symptoms,http://dx.doi.org/10.1038/hgv.2016.36,https://hgv.figshare.com/genome_variation/891,,
nonsense,Simpson-Golabi-Behmel syndrome (SGBS),312870,NM_004484,GPC3,300037,c.1330C>T,CAG，p.Gln444,TAG，stop codon,Xq26.2,132795841,uncertain,hemizygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2016.33,https://hgv.figshare.com/genome_variation/864,,
nonsense,Primary Congenital Glaucoma (PCG),231300,NM_000104.3,CYP1B1,601771,c.109C>T,CAG，p.Gln37,TAG，stop codon,2p21-22,38075280,inherited,homozygous,"1/10,000 （PCG occurs in approximately 1 in 10,000 live births, but the incidence varies widely between populations）",clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2016.21,https://hgv.figshare.com/genome_variation/835,,
nonsense,"Epileptic encephalopathy, early infantile, 2",300672,XM_005274584.1,CDKL5,300203,c.1675C>T,CGA，p.Arg559,TGA，stop codon,Xp22.13,18622719,de novo,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2015.42,https://hgv.figshare.com/genome_variation/723,,
nonsense,Warburg micro syndrome,600118,NM_001172435.1,RAB3GAP1,602536,c.22G>T,GAA，p.Glu8,TAA，stop codon,2q21.3,135810003,inherited,homozygous,N/A,molecular diagnosis,http://dx.doi.org/10.1038/hgv.2015.34,https://hgv.figshare.com/genome_variation/696,,
nonsense,"Spinal extradural arachnoid cyst (SEDAC), lymphedema-distichiasis syndrome(LDS)",153400,NM_005251.2,FOXC2,602402,c.349C>T,CAG，p.Gln117,TAG，stop codon,16q24.1,86601290,de novo / inherited,heterozygous,"1%（spinal extradural arachnoid cyst (SEDAC) is a relatively rare spinal disease, representing 1% of all primary spinal tumors）",an early detection enables surgery before irreversible neurological damage,http://dx.doi.org/10.1038/hgv.2015.32,https://hgv.figshare.com/genome_variation/690,,
nonsense,Severe congenital protein C (PC) deficiency,612304,NM_000312,PROC,612283,c.1003C>T,CAG，p.Gln335,TAG，stop codon,2q14.3,15144,inherited,heterozygous,more than 200 mutations affecting PC have been reported worldwide；the frequency of heterozygous mutations in PROC in the Japanese population has previously been estimated at 1 in 700 ,earlier diagnosis with prenatal genetic testing；domino liver transplantation for the treatment,http://dx.doi.org/10.1038/hgv.2015.17,https://hgv.figshare.com/genome_variation/588,,
nonsense,Serrated polyposis,,NM_017763.4,RNF43,612482,c.394C>T,CGA，p.Arg132,TGA，stop codon,17q22,56440943,inherited,heterozygous,N/A,exome sequencing；Bioinformatics；validation of candidate deleterious mutations,http://dx.doi.org/10.1038/hgv.2015.13,https://hgv.figshare.com/genome_variation/582,,
nonsense,Spastic paraplegia 7 (SPG7),607259,NM_003119,SPG7,602783,c.1192C>T,CGA，p.Arg398,TGA，stop codon,16q24.3,89598912,inherited,homozygous,N/A,WES analysis,http://dx.doi.org/10.1038/hgv.2015.12,https://hgv.figshare.com/genome_variation/580,,
missense,Beta-thalassemia,617980,NM_000518.5,HBB,141900,c.431A>T,CAC，p.His144,CTC，Leu,11p15.4,NC_000011.10: 5225611,uncertain,heterozygous,N/A,molecular DNA analysis,http://dx.doi.org/10.1038/s41439-024-00275-y,https://hgv.figshare.com/genome_variation/3394,,
missense,Hypertrophic cardiomyopathy (HCM),613690,NM_000363.5,TNNI3,191044,c.583A>T,ATC，p.Ile636,TTC，Phe,19q13.42,55663252,de novo,heterozygous,1/500（the prevalence of HCM is estimated to be at least 1 in 500 in the general population）,family genetic testing,http://dx.doi.org/10.1038/s41439-024-00272-1,https://hgv.figshare.com/genome_variation/3382,,
missense,Cardiospondylocarpofacial syndrome (CSCFS),157800,NM_003188,MAP3K7,602614,c.560C>T,ACC，p.Thr187,ATC，Ile,6q15,"grch37:chr6:91,266,266",de novo,heterozygous,only a few cases have been reported to date,there is no effective treatment,http://dx.doi.org/10.1038/s41439-024-00265-0,https://hgv.figshare.com/genome_variation/3365,,
missense,Episodic ataxia type 2 (EA2),108500,NM_001127222.2,CACNA1A,601011,c.1805T>G,CTG，p.Leu602,CGG，Arg,19p13.13,13419042,inherited,heterozygous,N/A,clinical symptoms caused by dumping syndrome,http://dx.doi.org/10.1038/s41439-023-00261-w,https://hgv.figshare.com/genome_variation/3357,,
missense,Oculodentodigital dysplasia (ODDD),164200,NM 000165.5,GJA1,121014,c.263C>T,CCC，p.Pro88,CTC，Leu,6q22.31,121768256,de novo,heterozygous,N/A,comprehensive genetic analysis,http://dx.doi.org/10.1038/s41439-023-00262-9,https://hgv.figshare.com/genome_variation/3354,,
missense,Neurofibromatosis type 1 (NF1),162200,NM_001042492.3,NF1,613113,c.3590C>T,GCA，p.Ala1197,GTA，Val,17q11.2,31233095(GRCh38),de novo,heterozygous,"1/2,000–1/3,000（n estimated birth prevalence of 1 in 2,000–3,000 individuals）",genetic analyses,http://dx.doi.org/10.1038/s41439-023-00256-7,https://hgv.figshare.com/genome_variation/3348,,
missense,Neurofibromatosis type 1 (NF1),162200,NM_001042492.3,NF1,613113,c.3586C>T,CTT，p.Leu1196,TTT，Phe,17q11.2,31233091(GRCh38),de novo,heterozygous,"1/2,000–1/3,000（n estimated birth prevalence of 1 in 2,000–3,000 individuals）",genetic analyses,http://dx.doi.org/10.1038/s41439-023-00256-7,https://hgv.figshare.com/genome_variation/3337,,
missense,Neurodevelopmental disorder with language delay and variable cognitive abnormalities,620502,NM_001470.4,GABBR1,603540,c.1042G>C,GCT，p.Ala348,CCT，Pro,6p22.1,29622127(GRCh38),de novo,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/s41439-023-00256-7,https://hgv.figshare.com/genome_variation/3343,,
missense,Centronuclear myopathy (CNM),615959,NM_005876.5,SPEG,615950,c.9391G>A,GAG，p.Glu3131,AAG，Lys,2q35,220356521,inherited,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/s41439-023-00253-w,https://hgv.figshare.com/genome_variation/3327,,
missense,Leigh-like syndrome with progressive cerebellar atrophy,250620,NM_014362.4,HIBCH,610690,c.782T>C,CTT，p.Leu261,CCT，Pro,2q32.2,191110907,inherited,heterozygous,N/A,valine-restricted diet,http://dx.doi.org/10.1038/s41439-023-00251-y,https://hgv.figshare.com/genome_variation/3315,,
missense,Developmental and epileptic encephalopathy (DEE),615871,NM_021072.4,HCN1,602780,c.1195T>C,TCT，p.Ser399,CCT，Pro,5p12,45396527(GRCH38),de novo,heterozygous,N/A,high-dose phenobarbital and potassium bromide were partially effective for the present patient；early genetic diagnosis,http://dx.doi.org/10.1038/s41439-023-00247-8,https://hgv.figshare.com/genome_variation/3311,,
missense,Congenital long QT syndrome (LQTS),617268,NM_001348768.2,HECW2,617245,c.4343T>C,TTG，p.Leu1448,TCG，Ser,2q32.3,196220104,de novo,heterozygous,"1/2,000 （congenital long QT syndrome (LQTS) affects 1 in 2000 infants）","the use of mexiletine, a voltage-gated sodium channel blocker, in combination with a beta-blocker ",http://dx.doi.org/10.1038/s41439-023-00245-w,https://hgv.figshare.com/genome_variation/3305,,
missense,Heterozygous HbG-Coushatta,N/A,NM_000518.5,HBB,141900,c.68A>C,GAA，p.Glu23,GCA，Ala,11p15.4,5226954,uncertain,heterozygous,very rare around the world,family studies and molecular genetic testing,http://dx.doi.org/10.1038/s41439-023-00243-y,https://hgv.figshare.com/genome_variation/3301,,
missense,SHQ1-associated neurodevelopmental disorder,619922,NM_018130,SHQ1,613663,c.833T>C,ATC，p.Ile278,ACC，Thr,3p13,NC_000003.11:g.72866430A>G (GRCH37),inherited,homozygous,N/A,clinical features ,http://dx.doi.org/10.1038/s41439-023-00234-z,https://hgv.figshare.com/genome_variation/3279,,
missense,Developmental and epileptic encephalopathy (DEE),300699,NM_007325.5,GRIA3,305915,c.1982T>C,ATG，p.Met661,ACG，Thr,Xq25,123428045,de novo,heterozygous,N/A,"carbamazepine has been reported to be effective for a patient with a gain-of-function variant13. In our case, carbamazepine was ineffective.We intend to classify antiepileptic medications while taking into account the use of perampanel, a noncompetitive AMPAR antagonist, as a first-line treatment.",http://dx.doi.org/10.1038/s41439-023-00232-1,https://hgv.figshare.com/genome_variation/3276,,
missense,Monogenic diabetes,125851,NM_001354800.1,GCK,138079,c.1135G>A,GCG，p.Ala379,ACG，Thr,7p13,44185214,inherited,heterozygous,"1/1,000（The estimated incidence of monogenic diabetes due to GCK mutations is 1 in 1000 individuals）",clinical next-generation sequencing,http://dx.doi.org/10.1038/s41439-023-00233-0,https://hgv.figshare.com/genome_variation/3270,,
missense,Familial renal glucosiuria (FRG),233100,NM_003041.4,SLC5A2,182381,c.1348G>T,GGG，p.Gly450,TGG，Trp,16p11.2,31488947,inherited,heterozygous,N/A,SGLT2 inhibitors have attracted attention as therapeutic agents for type 2 diabetes in recent years1；the analysis of the SLC5A2 gene and examination of the pathophysiology of FRG,http://dx.doi.org/10.1038/s41439-022-00221-w,https://hgv.figshare.com/genome_variation/3258,,
missense,Otopalatodigital spectrum disorder (OPDSD),304120,NM_001110556,FLNA,300017,c.583G>A,GGC，p.Gly195,AGC，Ser,Xq28,153596249 (GRCh37),inherited,hemizygous,N/A,genetic counseling,http://dx.doi.org/10.1038/s41439-022-00224-7,https://hgv.figshare.com/genome_variation/3249,,
missense,Achondrogenesis type II (ACG2),200610,NM_001844.5,COL2A1,120140,c.2987G>A,GGC，p.Gly996,GAC，Asp,12q13.11,48372090(GRCh37),de novo,heterozygous,N/A,postnatal genetic analysis,http://dx.doi.org/10.1038/s41439-022-00218-5,https://hgv.figshare.com/genome_variation/3246,,
missense,Cockayne syndrome (CS),133540,NM_000124.4,ERCC6,609413,c.1627A>T,ATT，p.Ile543,TTT，Phe,Xq13.3,49500596,uncertain,heterozygous,N/A,genetic counseling,http://dx.doi.org/10.1038/s41439-022-00212-x,https://hgv.figshare.com/genome_variation/3238,,
missense,Cockayne syndrome (CS),133540,NM_000124.4,ERCC6,609413,c.1931T>C,ATC，p.Ile644,ACC，Thr,Xq13.3,49483407,uncertain,heterozygous,N/A,genetic counseling,http://dx.doi.org/10.1038/s41439-022-00212-x,https://hgv.figshare.com/genome_variation/3232,,
missense,Biotin-responsive basal ganglia disease (BBGD),607483,NM_025243.4,SLC19A3,606152,c.265A>C,AGT，p.Ser89,CGT，Arg,2q36.3,228564166,inherited,heterozygous,10 cases of neonatal-onset BBGD have been reported to date,"although BBGD is a genetic condition that is treatable by initiation of thiamine and biotin treatment, neonatal onset may predict a poor prognosis；vitamin combination therapy may prevent a second attack or encephalopathy",http://dx.doi.org/10.1038/s41439-022-00210-z,https://hgv.figshare.com/genome_variation/3228,,
missense,Arrhythmogenic right ventricular cardiomyopathy (ARVC),610193,NM_001943.5,DSG2,125671,c.1592T>G,TTC，p.Phe531,TGC，Cys,18q12.1,31536370 (GRCh38/hg38),inherited,homozygous,"1/1,000-1/5,000（its prevalence is estimated to be 1 in 1000 to 5000 individuals）",precise genetic counseling,http://dx.doi.org/10.1038/s41439-022-00206-9,https://hgv.figshare.com/genome_variation/3210,,
missense,Autosomal dominant cerebellar ataxia (ADCA),616204,NM001510.4,GRID2,602368,c.1966C>G,CTC，p.Leu656,GTC，Val,4q22.2,94411897,inherited,heterozygous,N/A,whole-exome analysis,http://dx.doi.org/10.1038/s41439-022-00204-x,https://hgv.figshare.com/genome_variation/3207,,
missense,Cockayne syndrome (CS),133540,NM_000124.4,ERCC6,609413,c.2936A>G,AAG，p.Lys979,AGG，Arg,10q11.23,50679155,inherited,heterozygous,"ERCC6 mutations account for ~70% of cases, and ERCC8 mutations account for ~30%",whole-exome sequencing,http://dx.doi.org/10.1038/s41439-022-00200-1,https://hgv.figshare.com/genome_variation/3203,,
missense,Multiple intracranial hemorrhages and congenital cataracts,614519,NM_001845.6,COL4A1,120130,c.2291G>A,GGC，p.Gly764,GAC，Asp,13q34,110179324,de novo / inherited,heterozygous,N/A,molecular testing,http://dx.doi.org/10.1038/s41439-022-00199-5,https://hgv.figshare.com/genome_variation/3202,,
missense,Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC),612438,NM_006087.4,TUBB4A,602662,c.1088T>C,ATG，p.Met363,ACG，Thr,19p13.3,6495411(GRCh38),de novo,heterozygous,N/A,clinical onset in early infancy,http://dx.doi.org/10.1038/s41439-022-00198-6,https://hgv.figshare.com/genome_variation/3199,,
missense,Thyroid hypogenesis,615937,NM_005465.7,AKT3,611223,c.233A>G,CAG，p.Gln78,CGG，Arg,1q43-q44,243828125,de novo,heterozygous,"1/5,000（The prevalence of thyroid dysgenesis is approximately one in 5000 live births）",clinical features ,http://dx.doi.org/10.1038/s41439-022-00197-7,https://hgv.figshare.com/genome_variation/3195,,
missense,Epidermolysis bullosa (EB),226600,NM_000094.4,COL7A1,120120,c.6262G>A,GGA，p.Gly2088,AGA，Arg,3p21.31,48612514,de novo / inherited,heterozygous,N/A,clinical features ,http://dx.doi.org/10.1038/s41439-022-00192-y,https://hgv.figshare.com/genome_variation/3166,,
missense,Leigh syndrome (LS),N/A,NM_024678,NARS2,612803,c.556A>G,AAT，p.Asn186,GAT，Asp,11q14.1,78559577 (GRCh38),inherited,heterozygous,"1/40,000（Leigh syndrome has an estimated prevalence of 1 per 40,000 live births）",early diagnosis is crucial for optimizing care; avoidance of the drugs metabolized by the mitochondria is recommended；clinical characteristics；genetic counseling,http://dx.doi.org/10.1038/s41439-022-00191-z,https://hgv.figshare.com/genome_variation/3163,,
missense,Leigh syndrome (LS),N/A,NM_024678,NARS2,612803,c.731C>G,GCT，p.Ala244,GGT，Gly,11q14.1,78493154 (GRCh38),inherited,heterozygous,"1/40,000（Leigh syndrome has an estimated prevalence of 1 per 40,000 live births）",early diagnosis is crucial for optimizing care; avoidance of the drugs metabolized by the mitochondria is recommended；clinical characteristics；genetic counseling,http://dx.doi.org/10.1038/s41439-022-00191-z,https://hgv.figshare.com/genome_variation/3160,,
missense,Spondyloepiphyseal dysplasia congenita (SEDC),183900,NM_001844.5,COL2A1,120140,c.3508G>C,GGT，p.Gly1170,CGT，Arg,12q13.11,48369835 (GRCh37),de novo,heterozygous,"3.4/1,000,000（SEDC is a rare disease with a prevalence of 3.4/1,000,000）",clinical features,http://dx.doi.org/10.1038/s41439-022-00193-x,https://hgv.figshare.com/genome_variation/3152,,
missense,Spondyloepiphyseal dysplasia congenita (SEDC),183900,NM_001844.5,COL2A1,120140,c.1780G>A,GGG，p.Gly594,AGG，Arg,12q13.11,48378831 (GRCh37),inherited,heterozygous,"3.4/1,000,000（SEDC is a rare disease with a prevalence of 3.4/1,000,000）",clinical features,http://dx.doi.org/10.1038/s41439-022-00193-x,https://hgv.figshare.com/genome_variation/3149,,
missense,Spondyloepiphyseal dysplasia congenita (SEDC),183900,NM_001844.5,COL2A1,120140,c.1699G>A,GGT，p.Gly567,AGT，Ser,12q13.11,48379352 (GRCh37),de novo,heterozygous,"3.4/1,000,000（SEDC is a rare disease with a prevalence of 3.4/1,000,000）",clinical features,http://dx.doi.org/10.1038/s41439-022-00193-x,https://hgv.figshare.com/genome_variation/3146,,
missense,Spondyloepiphyseal dysplasia congenita (SEDC),183900,NM_001844.5,COL2A1,120140,c.1628G>A,GGA，p.Gly543,GAA，Glu,12q13.11,48379563 (GRCh37),inherited,heterozygous,"3.4/1,000,000（SEDC is a rare disease with a prevalence of 3.4/1,000,000）",clinical features,http://dx.doi.org/10.1038/s41439-022-00193-x,https://hgv.figshare.com/genome_variation/3143,,
missense,Spondyloepiphyseal dysplasia congenita (SEDC),183900,NM_001844.5,COL2A1,120140,c.1421G>T,GGC，p.Gly474,GTC，Val,12q13.11,48380225 (GRCh37),de novo,heterozygous,"3.4/1,000,000（SEDC is a rare disease with a prevalence of 3.4/1,000,000）",clinical features,http://dx.doi.org/10.1038/s41439-022-00193-x,https://hgv.figshare.com/genome_variation/3140,,
missense,Movement disorders,614820,NM_152296.5,ATP1A3,182350,c.2408G>A,GGC，p.Gly803,GAC，Asp,19q13.2,41970398(GRCh38),de novo,heterozygous,N/A,clinical phenotypes,http://dx.doi.org/10.1038/s41439-022-00184-y,https://hgv.figshare.com/genome_variation/3128,,
missense,Hypertrophic cardiomyopathy (HCM),N/A,NM_001134363.3,RBM20,613171,c.1907G>A,CGT，p.Arg636,CAT，His,10q25.2,112572062 (hg19),inherited,heterozygous,N/A,clinical features ,http://dx.doi.org/10.1038/s41439-022-00183-z,https://hgv.figshare.com/genome_variation/3122,,
missense,Medium-chain acyl-coenzyme A dehydrogenase deficinecy (MCADD),201450,N/A,ACADM,607008,c.1040G>T,GGT，p.Gly347,GTT，Val,75761216(GRCh38/hg38),N/A,inherited,heterozygous,"1/100,000（the prevalence of MCADD varies across ethnic groups; in Japan, it is estimated to be approximately 1 in 100,000 births, which is considerably lower than that in Western countries）","once the diagnosis is established, implementation of frequent feeding to avoid any prolonged fasting and appropriate management of periods of illness can be expected to almost completely prevent onset of the disease",http://dx.doi.org/10.1038/s41439-021-00177-3,https://hgv.figshare.com/genome_variation/3112,,
missense,Mullegama-Klein-Martinez syndrome (MKMS),301022,NM_001042749.2,STAG2,300826,c.475T>C,TAT，p.Tyr159,CAT，His,Xq25,123179026,inherited,hemizygous,"since the first case of MKMS was described in 20159, 17 other cases have been reported worldwide, of which only 3 are male",clinical features,http://dx.doi.org/10.1038/s41439-021-00169-3,https://hgv.figshare.com/genome_variation/3095,,
missense,Hyperprolinemia type I (HPI),239500,NM_06335.5,PRODH,606810,c.1562G>A,CGG，p.Arg521,CAG，Gln,22q11.21,18913491(GRCh38),inherited,homozygous,"very few case reports of patients with HPI have been reported worldwide, with only two described in Japan",plasma amino acid analysis；clinical phenotypes,http://dx.doi.org/10.1038/s41439-021-00159-5,https://hgv.figshare.com/genome_variation/3066,,
missense,Hyperprolinemia type I (HPI),239500,NM_06335.5,PRODH,606810,c.1414G>A,GCC，p.Ala472,ACC，Thr,22q11.21,18918329(GRCh38),inherited,homozygous,"very few case reports of patients with HPI have been reported worldwide, with only two described in Japan",plasma amino acid analysis；clinical phenotypes,http://dx.doi.org/10.1038/s41439-021-00159-5,https://hgv.figshare.com/genome_variation/3060,,
missense,Hyperprolinemia type I (HPI),239500,NM_06335.5,PRODH,606810,c.1397C>T,ACG，p.Thr466,ATG，Met,22q11.21,18918346(GRCh38),inherited,homozygous,"very few case reports of patients with HPI have been reported worldwide, with only two described in Japan",plasma amino acid analysis；clinical phenotypes,http://dx.doi.org/10.1038/s41439-021-00159-5,https://hgv.figshare.com/genome_variation/3057,,
missense,Hyperprolinemia type I (HPI),239500,NM_06335.5,PRODH,606810,c.553T>C,TGG，p.Trp185,CGG，Arg,22q11.21,18925165(GRCh38),inherited,homozygous,"very few case reports of patients with HPI have been reported worldwide, with only two described in Japan",plasma amino acid analysis；clinical phenotypes,http://dx.doi.org/10.1038/s41439-021-00159-5,https://hgv.figshare.com/genome_variation/3048,,
missense,Hyperprolinemia type I (HPI),239500,NM_06335.5,PRODH,606810,c.56C>A,CCG，p.Pro19,CAG，Gln,22q11.21,18936232(GRCh38),inherited,homozygous,"very few case reports of patients with HPI have been reported worldwide, with only two described in Japan",plasma amino acid analysis；clinical phenotypes,http://dx.doi.org/10.1038/s41439-021-00159-5,https://hgv.figshare.com/genome_variation/3048,,
missense,MIRAGE syndrome,617053,NM_017654.4,SAMD9,610456,c.1310T>C,TTT，p.Phe437,TCT，Ser,7q21.2,"chr7:93,104,788 (hg38)",de novo,heterozygous,N/A,clinical phenotypes,http://dx.doi.org/10.1038/s41439-021-00158-6,https://hgv.figshare.com/genome_variation/3042,,
missense,Frontometaphyseal dysplasia (FMD) type 2,617137,NM_001292034.3,TAB2,605101,c.1448C>T,CCT，p.Pro483,CTT，Leu,6q25.1,149700499(GRCh37),de novo,heterozygous,N/A,clinical features ,http://dx.doi.org/10.1038/s41439-021-00166-6,https://hgv.figshare.com/genome_variation/3036,,
missense,Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL),617804,NM_138615.2,DHX30,616423,c.2353C>T,CGC，p.Arg785,TGC，Cys,3p21.31,47848246,de novo,heterozygous,N/A,clinical features,http://dx.doi.org/10.1038/s41439-021-00155-9,https://hgv.figshare.com/genome_variation/3030,,
missense,Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL),617804,NM_138615.2,DHX30,616423,c.2354G>A,CGC，p.Arg785,CAC，His,3p21.31,47848247,de novo,heterozygous,N/A,clinical features,http://dx.doi.org/10.1038/s41439-021-00155-9,https://hgv.figshare.com/genome_variation/3027,,
missense,Neurodevelopmental disorder with severe motor impairment and absent language (NEDMIAL),617804,NM_138615.2,DHX30,616423,c.2345G>A,CGG，p.Arg782,CAG，Gln,3p21.31,47848238,de novo,heterozygous,N/A,clinical features,http://dx.doi.org/10.1038/s41439-021-00155-9,https://hgv.figshare.com/genome_variation/3024,,
missense,Type 2 diabetes (T2D),125853,NM_006193,PAX4,167413,c.574C>A,CGT，p.Arg192,AGT，Ser,7q32,chr7:127253551 (hg19),uncertain,heterozygous,East Asians are more likely to develop T2D at a lower body mass index than Europeans,genetic analyses,http://dx.doi.org/10.1038/s41439-021-00156-8,https://hgv.figshare.com/genome_variation/3021,,
missense,Type 2 diabetes (T2D),125853,NM_006193,PAX4,167413,c.575G>A,CGT，p.Arg192,CAT，His,7q32,chr7:127253550 (hg19),uncertain,heterozygous,East Asians are more likely to develop T2D at a lower body mass index than Europeans,genetic analyses,http://dx.doi.org/10.1038/s41439-021-00156-8,https://hgv.figshare.com/genome_variation/3018,,
missense,Spastic paraplegia 4,182601,NM_01946.4,SPAST,604277,c.1252G>A,GAA，p.Glu418,AAA，Lys,2p22.3,32361638,inherited,heterozygous,"15–40%（The most common type of HSP is spastic paraplegia 4 (SPG4, MIM: 182601), accounting for 15–40% of all HSP cases）",molecular diagnosis,http://dx.doi.org/10.1038/s41439-021-00153-x,https://hgv.figshare.com/genome_variation/3015,,
missense,Recurrent epistaxis and glioblastoma,175780,NM_001845.6,COL4A1,120130,c.3797G>T,GGT，p.Gly1266,GTT，Val,13,110822055(hg19),inherited,heterozygous,N/A,clinical phenotypes,http://dx.doi.org/10.1038/s41439-021-00150-0,https://hgv.figshare.com/genome_variation/3006,,
missense,"Infantile-onset multisystem neurologic, endocrine, and pancreatic disease (IMNEPD)",616263,NM_016077.5,PTRH2,608625,c.68T>C,GTT，p.Val23,GCT，Ala,17q23.1,57775272,inherited,homozygous,N/A,prenatal diagnosis,http://dx.doi.org/10.1038/s41439-021-00147-9,https://hgv.figshare.com/genome_variation/2987,,
missense,Venous thromboembolism (VTE),188050,NM_000506.4,F2,176930,c.1621C>T,CGG，p.Arg541,TGG，Trp,11p11.2,46729528 (GRCh38),inherited,heterozygous,"1/1,000-2/1,000 （it is estimated that VTE occurs approximately 1 to 2 per 1000 person-years among people of European descent1, with its risk assumed to be lower in Asians）",prophylactic anticoagulation；targeted gene panel testing or whole-exome sequencing,http://dx.doi.org/10.1038/s41439-021-00145-x,https://hgv.figshare.com/genome_variation/2981,,
missense,Arginase 1 deficiency,207800,NM_000045.4,ARG1,608313,c.820G>A,GAT，p.Asp274,AAT，Asn,6q23,131583759,inherited,heterozygous,"1/2,200,000（in Japan, the incidence of arginase 1 deficiency may be less than that in the United States and Europe, i.e., an incidence of 1:2,200,000, per a previous report）",genetic testing,http://dx.doi.org/10.1038/s41439-021-00139-9,https://hgv.figshare.com/genome_variation/2969,,
missense,Primary ciliary dyskinesia (PCD),604366,NM_001372.3,DNAH9,618300,c.1298C>G,TCT，p.Ser433,TGT，Cys,17p12,11523046,inherited,heterozygous,"1/20,000（Primary ciliary dyskinesia (PCD) occurs in approximately 1 in 20,000 live births）",clinical features,http://dx.doi.org/10.1038/s41439-020-00134-6,https://hgv.figshare.com/genome_variation/2957,,
missense,Complex hereditary spastic paraplegia (HSP),N/A,NM_001098.2,ACO2,100850,c.2148C>G,AAC，p.Asn716,AAG，Lys,22q13.2,41923966,inherited,heterozygous,N/A,should be evaluated for signs such as early-onset spastic paraplegia； the development of specific therapies against HSP caused by mitochondrial dysfunction,http://dx.doi.org/10.1038/s41439-021-00136-y,https://hgv.figshare.com/genome_variation/2954,,
missense,Complex hereditary spastic paraplegia (HSP),N/A,NM_001098.2,ACO2,100850,c.776G>A,GGT，p.Gly259,GAT，Asp,22q13.2,41911862,inherited,heterozygous,N/A,should be evaluated for signs such as early-onset spastic paraplegia； the development of specific therapies against HSP caused by mitochondrial dysfunction,http://dx.doi.org/10.1038/s41439-021-00136-y,https://hgv.figshare.com/genome_variation/2951,,
missense,Cryptogenic West syndrome,N/A,NM_001456.4,FLNA,300017,c.4804G>A,GGC，p.Gly1602,AGC，Ser,Xq28,153585943,de novo,hemizygous,approximately 30 male patients whose FLNA variants are predicted to be partially loss-of-function or mosaic have been reported to date,clinical features,http://dx.doi.org/10.1038/s41439-020-00131-9,https://hgv.figshare.com/genome_variation/2945,,
missense,Congenital hypothyroidism (CH),606765,NM_175719.3,TPO,606765,c.2315A>G,TAT，p.Tyr772,TGT，Cys,2p25,1500466,inherited,homozygous,"1/2,000-1/4,000 （Congenital hypothyroidism (CH) is diagnosed as thyroid hormone deficiency in newborn infants with an incidence of 1:2000 to 1:4000 live births worldwide）",genetic or blood-based screening；preventive therapies,http://dx.doi.org/10.1038/s41439-020-00129-3,https://hgv.figshare.com/genome_variation/2942,,
missense,Congenital hemolytic anemia,175780,NM_001845.6,COL4A1,120130,c.2843G>A,GGC，p.Gly948,GAC，Asp,13q34,110829258(GRCh37/hg19),de novo,heterozygous,N/A,clinical features,http://dx.doi.org/10.1038/s41439-020-00130-w,https://hgv.figshare.com/genome_variation/2939,,
missense,Congenital hemolytic anemia,175780,NM_001845.6,COL4A1,120130,c.2788G>A,GGT，p.Gly930,AGT，Ser,13q34,110829313(GRCh37/hg19),de novo,heterozygous,N/A,clinical features,http://dx.doi.org/10.1038/s41439-020-00130-w,https://hgv.figshare.com/genome_variation/2936,,
missense,Congenital hemolytic anemia,175780,NM_001845.6,COL4A1,120130,c.2537G>A,GGG，p.Gly846,GAG，Glu,13q34,110830500(GRCh37/hg19),de novo,heterozygous,N/A,clinical features,http://dx.doi.org/10.1038/s41439-020-00130-w,https://hgv.figshare.com/genome_variation/2933,,
missense,Congenital hemolytic anemia,175780,NM_001845.6,COL4A1,120130,c.2354G>T,GGA，p.Gly785,GTA，Val,13q34,110831374(GRCh37/hg19),de novo,heterozygous,N/A,clinical features,http://dx.doi.org/10.1038/s41439-020-00130-w,https://hgv.figshare.com/genome_variation/2930,,
missense,Long-QT syndrome (LQTS) and arrhythmia,612955,NM_003098.3,SNTA1,601017,c.1115C>T,ACG，p.Thr372,ATG，Met,20q11.21,31998063 (GRCh37),inherited,heterozygous,N/A,genetic testing,http://dx.doi.org/10.1038/s41439-020-00121-x,https://hgv.figshare.com/genome_variation/2921,,
missense,Jervell and Lange-Nielsen syndrome,220400,NM_000218.3,KCNQ1,607542,c.1040T>G,CTT，p.Leu347,CGT，Arg,11p15.5-p15.4,2606449 (GRCh37),inherited,heterozygous,N/A,genetic testing,http://dx.doi.org/10.1038/s41439-020-00121-x,https://hgv.figshare.com/genome_variation/2918,,
missense,Schizophrenia and bipolar disorder,N/A,NM_001290,LDB2,603450,c.248 C>A,none，p.Thr83,none，Asn,4p15.32,16597486 (GRCh37),uncertain,heterozygous,schizophrenia is a chronic and disabling brain disorder that affects approximately 1% of the population,genetic analyses,http://dx.doi.org/10.1038/s41439-020-00117-7,https://hgv.figshare.com/genome_variation/2909,,
missense,Arthrogryposis multiplex congenita with polymicrogyria and infantile encephalopathy,614254,NM_007327.3,GRIN1,138249,c.1949A>C,AAC，p.Asn650,ACC，Thr,9q34.3,140057127(GRCh37),de novo,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/s41439-020-00116-8,https://hgv.figshare.com/genome_variation/2900,,
missense,Xeroderma pigmentosum group D (XPD),278730,NM_000400.3,ERCC2,126340,c.1003C>G,CGG，p.Arg335,GGG，Gly,19q13.32,45867116,inherited,heterozygous,N/A,comprehensive genetic testing；early diagnosis and continual and accurate monitoring,http://dx.doi.org/10.1038/s41439-020-0109-z,https://hgv.figshare.com/genome_variation/2876,,
missense,Tatton-Brown-Rahman syndrome (TBRS),615879,NM_175629,DNMT3A,602769,c.1904G>A,CGG，p.Arg635,CAG，Gln,2p23.3,25466799,de novo,heterozygous,"to date, there are approximately 80 reported cases",clinical features,http://dx.doi.org/10.1038/s41439-020-0102-6,https://hgv.figshare.com/genome_variation/2844,,
missense,Carnitine-acylcarnitine translocase (CACT) deficiency,212138,NM_000387.6,SLC25A20,613698,c.824G>A,CGA，p.Arg275,CAA，Gln,3p21,48895959 (GRCh37),de novo / inherited,homozygous,N/A,clinical features,http://dx.doi.org/10.1038/s41439-020-0098-y,https://hgv.figshare.com/genome_variation/2841,,
missense,Limb-girdle muscular dystrophy type 2I,607155,NM_001039885.2,FKRP,606596,c.169G>A,GAG，p.Glu57,AAG，Lys,19q13.32,46755619,inherited,heterozygous,"4.3/1,000,000（The prevalence of dystrophinopathy (DMD and Becker-type muscular dystrophy) has been reported5 to be ~2 per 10,000, whereas the prevalence of LGMD2I is 4.3 per million）",FKRP gene analysis,http://dx.doi.org/10.1038/s41439-020-0099-x,https://hgv.figshare.com/genome_variation/2838,,
missense,MIRAGE syndrome,617053,NM_017654.4,SAMD9,610456,c.4435G>T,GCA，p.Ala1479,TCA，Ser,7q21.2,93101663,de novo,heterozygous,"to date, ~40 cases of MIRAGE syndrome have been reported",early genetic diagnosis together with the confirmation of age-dependent additional genetic features will help predict the clinical characteristics of patients and enable early and appropriate intervention,http://dx.doi.org/10.1038/s41439-020-0091-5,https://hgv.figshare.com/genome_variation/2811,,
missense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.372G>C,none，p.Leu124,none，Phe,Xq28,153297663,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2777,,
missense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.916C>T,none，p.Arg306,none，Cys,Xq28,153296363,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2765,,
missense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.674C>G,none，p.Pro225,none，Arg,Xq28,153296605,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2762,,
missense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.547C>T,none，p.Thr158,none，Met,Xq28,153296806,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2759,,
missense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.925C>T,none，p.Arg309,none，Trp,Xq28,153296354,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2738,,
missense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.310T>C,none，p.Trp104,none，Arg,Xq28,153297725,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2735,,
missense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.455C>G,none，p.Pro152,none，Arg,Xq28,153296824,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2729,,
nonsense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.471C>T,none，p.Arg133,none，Cys,Xq28,153296882,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2723,,
missense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.398G>T,none，p.Arg133,none，Leu,Xq28,153296881,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2708,,
missense,Rett syndrome,312750,NM_004992.3,MECP2,300005,c.916C>T,none，p.Arg306,none，Cys,Xq28,153296363,de novo,heterozygous,"1/10,000（a prevalence of one in 10,000 worldwide）",genetic testing,http://dx.doi.org/10.1038/s41439-019-0078-2,https://hgv.figshare.com/genome_variation/2705,,
missense,Arrhythmogenic right ventricular cardiomyopathy (ARVC),610193,NM_001943.3,DSG2,125671,c.1592T>G,TTC，p.Phe531,TGC，Cys,18q12.1,29116333,inherited,heterozygous,"1/2,000-1/5,000",precise genetic counseling,http://dx.doi.org/10.1038/s41439-019-0069-3,https://hgv.figshare.com/genome_variation/2600,,
missense,Arrhythmogenic right ventricular cardiomyopathy (ARVC),610193,NM_001943.4,DSG2,125671,c.146G>A,CGC，p.Arg49,CAC，His,18q12.1,29099830,inherited,heterozygous,"1/2,000-1/5,000",precise genetic counseling,http://dx.doi.org/10.1038/s41439-019-0069-3,https://hgv.figshare.com/genome_variation/2597,,
missense,Moyamoya disease (MMD),607151,NM_001256071.2,RNF213,613768,c.12562G>A,GCT，p.Ala4188,ACT，Thr,17q25.3,80372545 (GRCh38),inherited,heterozygous,N/A,unique angiographic and clinical features,http://dx.doi.org/10.1038/s41439-019-0066-6,https://hgv.figshare.com/genome_variation/2591,,
missense,Moyamoya disease (MMD),607151,NM_001256071.2,RNF213,613768,c.12553A>G,AAG，p.Lys4185,GAG，Glu,17q25.3,80372536 (GRCh38),inherited,heterozygous,N/A,unique angiographic and clinical features,http://dx.doi.org/10.1038/s41439-019-0066-6,https://hgv.figshare.com/genome_variation/2588,,
missense,CLOVES syndrome with concurrent pancreatic steatosis (PS),612918,NM_006218.3,PIK3CA,171834,c.1357G>A,GAA，p.Glu453,AAA，Lys,3q26,178928079 (hg19),de novo,heterozygous,N/A,pancreatic screening；histological analysis or imaging,http://dx.doi.org/10.1038/s41439-019-0063-9,https://hgv.figshare.com/genome_variation/2585,,
missense,Macrocephaly/Autism syndrome,605309,NM_000314.4,PTEN,601728,c.959T>C,TTA，p.Leu320,TCA，Ser,10q23.31,89720808,de novo,heterozygous,N/A,cancer surveillance strategies,http://dx.doi.org/10.1038/s41439-019-0056-8,https://hgv.figshare.com/genome_variation/2579,,
missense,Leigh syndrome (LS),256000,NM_004092.4,ECHS1,602292,c.176A>G,AAT，p.Asn59,AGT，Ser,10q26.3,135184174,inherited,heterozygous,N/A,"some dietary treatments, such as valine restriction, may decrease the production of toxic metabolites and mitigate disease；genetic screening",http://dx.doi.org/10.1038/s41439-019-0050-1,https://hgv.figshare.com/genome_variation/2561,,
missense,Leigh syndrome (LS),256000,NM_004092.4,ECHS1,602292,c.23T>C,CTG，p.Leu8,CCG，Pro,10q26.3,135186815,inherited,heterozygous,N/A,"some dietary treatments, such as valine restriction, may decrease the production of toxic metabolites and mitigate disease；genetic screening",http://dx.doi.org/10.1038/s41439-019-0050-1,https://hgv.figshare.com/genome_variation/2558,,
missense,Cone-rod dystrophy (CRD),613660,NM_033100.3,CDHR1,609502,c.2027T＞A,ATC，p.Ile676,AAC，Asn,10q23.1,84213335 (GRCh38/hg38),inherited,heterozygous,N/A,whole-exome sequencing (WES),http://dx.doi.org/10.1038/s41439-019-0048-8,https://hgv.figshare.com/genome_variation/2552,,
missense,Glomerulopathy with fibronectin deposits (GFND) ,601894,NM_212482,FN1,601894,c.3051G>T,TGG，p.Trp1017,TGT，Cys,2q34,216225177-216300791,inherited,heterozygous,two studies have shown an association between GFND and mutations in the FN 1 (FN1) gene in up to 50% of patients,preserving renal function and reducing proteinuria；dialysis and renal transplant,http://dx.doi.org/10.1038/s41439-019-0042-1,https://hgv.figshare.com/genome_variation/2537,,
missense,Usher syndrome type I (USH1),276900,NM_022124.5,CDH23,601067,c.130G>A,GAG，p.Glu44,AAG，Lys,10q22.1,73206137 (GRCh37/hg19),inherited,heterozygous,"3.2/100,000–4.4/100,000（The frequency of Usher syndrome has been estimated to be 3.2–4.4 per 100,000 people in Europe and the United States）",genetic counseling,http://dx.doi.org/10.1038/s41439-019-0037-y,https://hgv.figshare.com/genome_variation/2519,,
missense,Loeys–Dietz syndrome (LDS),609192,NM_001130916.2,TGFBR1,190181,c.1126A>G,AAA，p.Lys376,GAA，Glu,9q22.33,99144884,de novo,heterozygous,N/A,clinical features and genetic analysis,http://dx.doi.org/10.1038/s41439-019-0038-x,https://hgv.figshare.com/genome_variation/2516,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.667T>C,TGT，p.Cys223,CGT，Arg,Xp22.2-p22.1,18660132,inherited,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2507,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.657C>G,TGC，p.Cys219,TGG，Trp,Xp22.2-p22.1,18660142,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2504,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.638G>A,CGG，p.Arg213,CAG，Gln,Xp22.2-p22.1,18660161,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2501,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.625C>A,CGC，p.Arg209,AGC，Ser,Xp22.2-p22.1,18660174,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2498,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.625C>T,CGC，p.Arg209,TGC，Cys,Xp22.2-p22.1,18660174,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2495,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.608C>T,CCG，p.Pro203,CTG，Leu,Xp22.2-p22.1,18660191,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2492,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.599G>A,CGC，p.Arg200,CAC，His,Xp22.2-p22.1,18660200,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2489,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.598C>T,CGC，p.Arg200,TGC，Cys,Xp22.2-p22.1,18660201,inherited,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2486,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.590G>A,CGC，p.Arg197,CAC，His,Xp22.2-p22.1,18660209,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2483,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.589C>T,CGC，p.Arg197,TGC，Cys,Xp22.2-p22.1,18660210,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2480,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.574C>T,CCC，p.Pro192,TCC，Ser,Xp22.2-p22.1,18660225,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2477,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.544C>T,CGC，p.Arg182,TGC，Cys,Xp22.2-p22.1,18660255,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2474,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.438G>C,GAG，p.Glu146,GAC，Asp,Xp22.2-p22.1,18662634,inherited,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2465,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.422G>A,CGC，p.Arg141,CAC，His,Xp22.2-p22.1,18662650,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2462,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.417G>T,CAG，p.Gln139,CAT，His,Xp22.2-p22.1,18662655,inherited,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2459,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.404G>A,GGG，p.Gly135,GAG，Glu,Xp22.2-p22.1,18662668,inherited,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2456,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.326G>C,GGG，p.Gly109,GCG，Ala,Xp22.2-p22.1,18665311,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2450,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.305G>A,CGG，p.Arg102,CAG，Gln,Xp22.2-p22.1,18665332,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2447,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.304C>T,CGG，p.Arg102,TGG，Trp,Xp22.2-p22.1,18665333,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2444,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.301G>C,GCC，p.Ala101,CCC，Pro,Xp22.2-p22.1,18665336,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2441,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.266A>G,TAT，p.Tyr89,TGT，Cys,Xp22.2-p22.1,18665371,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2432,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.218C>T,TCA，p.Ser73,TTA，Leu,Xp22.2-p22.1,18665419,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2429,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.214G>A,GAG，p.Glu72,AAG，Lys,Xp22.2-p22.1,18665423,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2426,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.175T>G,TGT，p.Cys59,GGT，Gly,Xp22.2-p22.1,18674782,inherited,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2420,,
missense,X-linked congenital retinoschisis (XLRS),312700,NM_000330.3,RS1,300839,c.35T>C,CTT，p.Leu12,CCT，Pro,Xp22.2-p22.1,18690154,uncertain,hemizygous,"14/10,000（XLRS is the most common inherited retinal disorder; its highest reported prevalence is 14 per 10,000 individuals in Finland）",exact genetic determinations,http://dx.doi.org/10.1038/s41439-018-0034-6,https://hgv.figshare.com/genome_variation/2408,,
missense,Mayer–Rokitansky–Küster–Hauser (MRKH),277000,NM_002829,PTPN3,176877,c.1201A>C,AAT，p.Asn401,CAT，His,9q31.3,112182816,de novo,heterozygous,"1/4,500（MRKH syndrome occurs at a rate of 1 in 4500 newborn girls）",genome-wide single-nucleotide polymorphism (SNP) analyses and exome analysis,http://dx.doi.org/10.1038/s41439-018-0028-4,https://hgv.figshare.com/genome_variation/2387,,
missense,Mayer–Rokitansky–Küster–Hauser (MRKH),277000,NM_001024383,NAV3,611629,c.1516A>G,ATC，p.Ile506,GTC，Val,12q.21.2,78400834,de novo,heterozygous,"1/4,500（MRKH syndrome occurs at a rate of 1 in 4500 newborn girls）",genome-wide single-nucleotide polymorphism (SNP) analyses and exome analysis,http://dx.doi.org/10.1038/s41439-018-0028-4,https://hgv.figshare.com/genome_variation/2384,,
missense,Mayer–Rokitansky–Küster–Hauser (MRKH),277000,NM_015057,MYCBP2,610392,c.5156A>C,CAC，p.His1719,CCC，Pro,13q22.3,77752067,uncertain,heterozygous,"1/4,500（MRKH syndrome occurs at a rate of 1 in 4500 newborn girls）",genome-wide single-nucleotide polymorphism (SNP) analyses and exome analysis,http://dx.doi.org/10.1038/s41439-018-0028-4,https://hgv.figshare.com/genome_variation/2381,,
missense,Mayer–Rokitansky–Küster–Hauser (MRKH),277000,NM_015057,MYCBP2,610392,c.10762A>G,ACT，p.Thr3588,GCT，Ala,13q22.3,77661732,de novo,heterozygous,"1/4,500（MRKH syndrome occurs at a rate of 1 in 4500 newborn girls）",genome-wide single-nucleotide polymorphism (SNP) analyses and exome analysis,http://dx.doi.org/10.1038/s41439-018-0028-4,https://hgv.figshare.com/genome_variation/2378,,
missense,3M Syndrome,273750,NM_014780.4,CUL7,273750,c.4355G>A,GGC，p.Gly1452,GAC，Asp,6p21.1,43038927,inherited,heterozygous,CUL7 mutation is found in 65% of 3M syndrome patients,targeted next-generation sequencing,http://dx.doi.org/10.1038/s41439-018-0029-3,https://hgv.figshare.com/genome_variation/2375,,
missense,Neurological disorders – leukodystrophy and autism,300055,NM_004992.3,MECP2,300005,c.499C>T,CGG，p.Arg167,TGG，Trp,Xq28,153296780,inherited,hemizygous,N/A,genetic diagnosis,http://dx.doi.org/10.1038/s41439-018-0020-z,https://hgv.figshare.com/genome_variation/2354,,
missense,Hypomyelinating leukodystrophies (HLDs) ,612233,NM_002156.4,HSPD1,118190,c.139T>G,TTA，p.Leu47,GTA，Val,2q33.1,198363434,de novo,heterozygous,N/A,genetic diagnosis,http://dx.doi.org/10.1038/s41439-018-0020-z,https://hgv.figshare.com/genome_variation/2351,,
missense,Intellectual disability and autistic,N/A,NM_005338.6,HIP1,601767,c.1393G>A,GAA，p.Glu465,AAA，Lys,7q11.23,75187542,de novo,heterozygous,N/A,genetic diagnosis,http://dx.doi.org/10.1038/s41439-018-0020-z,https://hgv.figshare.com/genome_variation/2348,,
missense,Non-syndromic intellectual disability,N/A,NM_021007.2,SCN2A,182390,c.4378G>C,GGT，p.Gly1460,CGT，Arg,2q24.3,166237171,de novo,heterozygous,N/A,genetic diagnosis,http://dx.doi.org/10.1038/s41439-018-0019-5,https://hgv.figshare.com/genome_variation/2345,,
missense,LMNA-associated congenital muscular dystrophy,613205,NM_170707.3,LMNA,150330,c.115A>C,AAT，p.Asn39,CAT，His,1q22,156084824,de novo,heterozygous,N/A,molecular diagnosis,http://dx.doi.org/10.1038/s41439-018-0018-6,https://hgv.figshare.com/genome_variation/2342,,
missense,Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD),167320,NM_007126.3,VCP,601023,c.376A>G,ATT，p.Ile126,GTT，Val,9p13.3,35066741,de novo,heterozygous,VCP mutations account for 2% of familial amyotrophic lateral sclerosis (ALS) cases. The prevalence of the disease is not known in Japan.,clinical features,http://dx.doi.org/10.1038/s41439-018-0009-7,https://hgv.figshare.com/genome_variation/2315,,
missense,Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD),167320,NM_007126.3,VCP,601023,c.259G>T,GTT，p.Val87,TTT，Phe,9p13.3,35067931,de novo,heterozygous,VCP mutations account for 2% of familial amyotrophic lateral sclerosis (ALS) cases. The prevalence of the disease is not known in Japan.,clinical features,http://dx.doi.org/10.1038/s41439-018-0009-7,https://hgv.figshare.com/genome_variation/2312,,
missense,Ectodermal dysplasias (EDs),616069,NM_005228,EGFR,131550,c.1094T>A,ATC，p.Ile365,ATA，Asn,7p11.2,55224313,inherited,heterozygous,N/A,patients with biallelic mutations of EGFR can be diagnosed with ED,http://dx.doi.org/10.1038/s41439-018-0011-0,https://hgv.figshare.com/genome_variation/2306,,
missense,Branchio-Oculo-Facial Syndrome (BOFS),113620,NM_003220.2,TFAP2A,107580,c.699A>C,GAA，p.Glu233,GAC，Asp,6p24.3,10404806,inherited,heterozygous,N/A,phenotypic and genetic detection,http://dx.doi.org/10.1038/s41439-018-0004-z,https://hgv.figshare.com/genome_variation/1936,,
missense,Hypochondroplasia (HCH),14600,AF_238374,FGFR3,134934,c.805A>T,AGC，p.Ser269,TGC，Cys,4p16.3,1793299,de novo,heterozygous,N/A,genetic diagnosis,http://dx.doi.org/10.1038/s41439-018-0001-2,https://hgv.figshare.com/genome_variation/1920,,
missense,Okur-Chung neurodevelopmental syndrome (OCNDS),617062,NM_001895.3,CSNK2A1,115440,c.593A>G,AAA，p.Lys198,AGA，Arg,20p13,472926,de novo,heterozygous,N/A,dysmorphic features and behavioral problems,http://dx.doi.org/10.1038/hgv.2018.11,https://hgv.figshare.com/genome_variation/1917,,
missense,Pelizaeus-Merzbacher disease (PMD),300401,NM_000533.4,PLP1,312080,c.151T>G,TTC，p.Phe51,GTC，Val,Xq22.2,103773718,inherited,hemizygous,"1/50,000（PMD occurs in ~1/50,000 live male births worldwide）",genetic symptoms,http://dx.doi.org/10.1038/hgv.2018.13,https://hgv.figshare.com/genome_variation/1761,,
missense,Hyperphosphatasia with mental retardation syndrome (HPMRS),615716,NM_033419.4,PGAP3,611801,c.314C>A,CCG，p.Pro105,CAG，Gln,17q12,37840968,inherited,homozygous,"to date, 15 PGAP3 mutations have been reported in humans",clinical features ,http://dx.doi.org/10.1038/hgv.2018.5,https://hgv.figshare.com/genome_variation/1755,,
missense,Moyamoya disease (MMD),607151,NM_001256071.1,RNF213,613768,c.12185G>A,CGG，p.Arg4062,CAG，Gln,17q25.3,78343331(hg19),uncertain,heterozygous,N/A,unique angiographic and clinical features,http://dx.doi.org/10.1038/hgv.2017.60,https://hgv.figshare.com/genome_variation/1753,,
missense,Moyamoya disease (MMD),607151,NM_001256071.1,RNF213,613768,c.12173A>C,CAT，p.His4058,CCT，Pro,17q25.3,78343319(hg19),uncertain,heterozygous,N/A,unique angiographic and clinical features,http://dx.doi.org/10.1038/hgv.2017.60,https://hgv.figshare.com/genome_variation/1750,,
missense,Moyamoya disease (MMD),607151,NM_001256071.1,RNF213,613768,c.2986G>A,CAG，p.Glu996,AAG，Lys,17q25.3,78293074(hg19),uncertain,heterozygous,N/A,unique angiographic and clinical features,http://dx.doi.org/10.1038/hgv.2017.60,https://hgv.figshare.com/genome_variation/1747,,
missense,Spondyloepiphyseal dysplasia congenita (SEDC),183900,NM_001844.4,COL2A1,183900,c.1150G>A,GGT，p.Gly384,AGT，Ser,12q13.11,47987682,de novo,heterozygous,"3.4/1,000,000（SEDC is a rare disease with a prevalence of 3.4/1,000,000）",clinical features,http://dx.doi.org/10.1038/hgv.2017.59,https://hgv.figshare.com/genome_variation/1741,,
missense,G6PD deficiency,300908,NM_001042351.2,G6PD,305900,c.593G>A,CGC，p.Arg198,CAC，His,Xq28,153762604,de novo / inherited,heterozygous,"2-15%（in addition to Sardinia and Sicily, where higher disease prevalence is present (from 2 to 15%), G6PD-deficient subjects are also found in other Italian regions）",a clinical picture of the patient and residual enzymatic activity；next-generation sequencing,http://dx.doi.org/10.1038/hgv.2017.57,https://hgv.figshare.com/genome_variation/1738,,
missense,Congenital tooth agenesis,150400,NM_025216.2,WNT10A,606268,c.889G>A,GCC，p.Ala297,ACC，Thr,2q35,218892906,de novo,heterozygous,0.08–0.16%（Congenital tooth agenesis is highly heritable and observed in the general population with racial/ethnic difference in prevalence of 0.08–0.16%）,clinical features,http://dx.doi.org/10.1038/hgv.2017.47,https://hgv.figshare.com/genome_variation/1660,,
missense,Congenital tooth agenesis,150400,NM_025216.2,WNT10A,606268,c.637G>A,GGC，p.Gly213,AGC，Ser,2q35,218890244,de novo / inherited,heterozygous,0.08–0.16%（Congenital tooth agenesis is highly heritable and observed in the general population with racial/ethnic difference in prevalence of 0.08–0.16%）,clinical features,http://dx.doi.org/10.1038/hgv.2017.47,https://hgv.figshare.com/genome_variation/1657,,
missense,Congenital tooth agenesis,150400,NM_025216.2,WNT10A,606268,c.511C>T,CGT，p.Arg171,TGT，Cys,2q35,218890118,inherited,heterozygous,0.08–0.16%（Congenital tooth agenesis is highly heritable and observed in the general population with racial/ethnic difference in prevalence of 0.08–0.16%）,clinical features,http://dx.doi.org/10.1038/hgv.2017.47,https://hgv.figshare.com/genome_variation/1654,,
missense,Congenital tooth agenesis,150400,NM_025216.2,WNT10A,606268,c.143G>A,CGC，p.Arg48,CAC，His,2q35,218882190,de novo,heterozygous,0.08–0.16%（Congenital tooth agenesis is highly heritable and observed in the general population with racial/ethnic difference in prevalence of 0.08–0.16%）,clinical features,http://dx.doi.org/10.1038/hgv.2017.47,https://hgv.figshare.com/genome_variation/1651,,
missense,Marshall–Stickler syndrome,108300,NM_001844,COL2A1,120140,c.2710C>T,CGC，p.Arg904,TGC，Cys,12q13.11,48366748,de novo,heterozygous,N/A,molecular genetic analysis；molecular diagnosis,http://dx.doi.org/10.1038/hgv.2017.40,https://hgv.figshare.com/genome_variation/1648,,
missense,Intermediate autosomal recessive osteopetrosis,259710,NM_001287.5,CLCN7,602727,c.1729G>A,GTG，p.Val577,ATG，Met,16p13.3,1499035 (hg19),inherited,heterozygous,N/A,targeted exome sequencing,http://dx.doi.org/10.1038/hgv.2017.36,https://hgv.figshare.com/genome_variation/1402,,
missense,Intermediate autosomal recessive osteopetrosis,259710,NM_001287.5,CLCN7,602727,c.1505G>A,TGC，p.Cys502,TAC，Tyr,16p13.3,1500610 (hg19),inherited,heterozygous,N/A,targeted exome sequencing,http://dx.doi.org/10.1038/hgv.2017.36,https://hgv.figshare.com/genome_variation/1399,,
missense,Hypomyelinating leukodystrophies (HLDs) ,612438,NM_006087.3,TUBB4A,602662,c.286G>A,GGA，p.Gly96,AGA，Arg,19p13.3,6496224,de novo,heterozygous,N/A,"the neurological phenotype, the clinical features and the amino acid change",http://dx.doi.org/10.1038/hgv.2017.35,https://hgv.figshare.com/genome_variation/1396,,
missense,Bernard–Soulier syndrome (BSS) ,231200,NM_000174.4,GP9,173515,c.266G>A,TGT，p.Cys89,TAT，Tyr,3q21.3,129062005,inherited,heterozygous,"1/1,000,000 (homozygous);  1/500 (heterozygous)（ The estimated frequency of homozygous cases is as low as one per million population based on case reports, and the frequency of the heterozygous genotype is 1 in 500 as projected using the Hardy–Weinberg equilibrium (1998/1 000 000)）",clinical characteristics,http://dx.doi.org/10.1038/hgv.2017.30,https://hgv.figshare.com/genome_variation/1384,,
missense,Bernard–Soulier syndrome (BSS) ,231200,NM_000174.4,GP9,173515,c.182A>G ,AAC，p.Asn61,AGC，Ser,3q21.3,129061921,inherited,heterozygous,"1/1,000,000 (homozygous);  1/500 (heterozygous)（ The estimated frequency of homozygous cases is as low as one per million population based on case reports, and the frequency of the heterozygous genotype is 1 in 500 as projected using the Hardy–Weinberg equilibrium (1998/1 000 000)）",clinical characteristics,http://dx.doi.org/10.1038/hgv.2017.30,https://hgv.figshare.com/genome_variation/1381,,
missense,X-linked intellectual disability type Nascimento,300860,NM_003336.3,UBE2A,312180,c.76G>A,GGG，p.Gly26,AGG，Arg,Xq24,118708895,inherited,hemizygous,the prevalence of intellectual disability (ID) has been estimated at 1% of the worldwide population,whole-exome sequencing；clinical phenotype,http://dx.doi.org/10.1038/hgv.2017.19,https://hgv.figshare.com/genome_variation/1361,,
missense,Smith–Lemli–Opitz syndrome (SLOS),270400,LC201749,DHCR7,602858,c.1325A>G,CAC，p.His442,CGC，Arg,11q13.4,71435478,inherited,heterozygous,"1/20,000–1/60,000（SLOS incidence is estimated as 1:20,000–1:60,000 in Europe, but it is lower in other areas and is extremely rare in Japan0",cholesterol treatment,http://dx.doi.org/10.1038/hgv.2017.15,https://hgv.figshare.com/genome_variation/1348,,
missense,Supernumerary teeth,187100,NM_198455,SSPO,N/A,c.7733G>A,CGC，p.Arg2578,CAC，His,7q36.1,149500107,de novo / inherited,heterozygous,0.1-3.6%（the frequency of this condition in permanent dentition ranges from approximately 0.1 to 3.6%）,whole-exome sequencing,http://dx.doi.org/10.1038/hgv.2016.46,https://hgv.figshare.com/genome_variation/947,,
missense,Supernumerary teeth,187100,NM_198455,SSPO,N/A,c.8894G>A,TGC，p.Cys2965,TAC，Tyr,7q36.1,149504070,de novo / inherited,heterozygous,0.1-3.6%（the frequency of this condition in permanent dentition ranges from approximately 0.1 to 3.6%）,whole-exome sequencing,http://dx.doi.org/10.1038/hgv.2016.46,https://hgv.figshare.com/genome_variation/944,,
missense,Supernumerary teeth,187100,NM_198455,SSPO,N/A,c.6653A>T,CAG，p.Gln2218,CTG，Leu,7q36.1,149493577,de novo / inherited,heterozygous,0.1-3.6%（the frequency of this condition in permanent dentition ranges from approximately 0.1 to 3.6%）,whole-exome sequencing,http://dx.doi.org/10.1038/hgv.2016.46,https://hgv.figshare.com/genome_variation/938,,
missense,Spondyloepiphyseal dysplasia congenita (SEDC),183900,NM_001844,COL2A1,120140,c.3969C>G,TGC，p.Cys1323,TGG，Trp,12q13.11,47974780,de novo,heterozygous,"3.4/1,000,000（SEDC is a rare disease with a prevalence of 3.4/1,000,000）",clinical features,http://dx.doi.org/10.1038/hgv.2017.3,https://hgv.figshare.com/genome_variation/935,,
missense,Fabry disease (FD),301500,NM_000169,GLA,300644,c.431G>A,GGC，p.Gly144,GAC，Asp,Xq22.1,144,inherited,hemizygous,N/A,evaluated by plasma globotriaosylsphingosine levels,http://dx.doi.org/10.1038/hgv.2017.2,https://hgv.figshare.com/genome_variation/932,,
missense,Fabry disease (FD),301500,NM_000169,GLA,300644,c.207C>A,TTC，p.Phe69,TTA，Leu,Xq22.1,100658961,uncertain,hemizygous,"1/1,250-1/11,700（The estimated disease incidence ranges from 1 in 1250 to 1 in 11700 live male births）",genetic analyses,http://dx.doi.org/10.1038/hgv.2015.44,https://hgv.figshare.com/genome_variation/705,,
missense,Pulmonary alveolar microlithiasis (PAM),265100,NM_006024.2,SLC34A2,604217,c.1390G>C,GGC，p.Gly464,CGC，Arg,4p15.2,N/A,uncertain,heterozygous,"more than 1,000 cases of PAM have been reported since the first case was described by Malpighi in 1686,4 but to date only 33 patients have been diagnosed with mutations in SLC34A2",molecular analyses,http://dx.doi.org/10.1038/hgv.2016.47,https://hgv.figshare.com/genome_variation/929,,
missense,Pelizaeus-Merzbacher disease (PMD),312080,NM_000533,PLP1,300401,c.718T>C,TTT，p.Phe240,CTT，Leu,Xq22.2,103044283,inherited,hemizygous,N/A,clinical features,http://dx.doi.org/10.1038/hgv.2016.44,https://hgv.figshare.com/genome_variation/920,,
missense,Progressive pseudorheumatoid dysplasia (PPD),208230,NM_198239.1,WISP3,603400,c.721T>G,TGT，p.Cys241,GGT，Gly,6q22,112068239,inherited,heterozygous,"to date, 55 WISP3 mutations have been reported globally, 12 of which were from Chinese patients.",whole-exome sequencing,http://dx.doi.org/10.1038/hgv.2016.41,https://hgv.figshare.com/genome_variation/906,,
missense,Progressive pseudorheumatoid dysplasia (PPD),208230,NM_198239.1,WISP3,603400,c.396T>G,TGT，p.Cys132,TGG，Trp,6q22,112061284,inherited,heterozygous,"to date, 55 WISP3 mutations have been reported globally, 12 of which were from Chinese patients.",whole-exome sequencing,http://dx.doi.org/10.1038/hgv.2016.41,https://hgv.figshare.com/genome_variation/903,,
missense,Autosomal recessive retinitis pigmentosa (RP),613810,NM_000440.2,PDE6A,180072,c.304C>A,CGC，p.ArgR102,AGC，Ser,5q,"chr5:149,857,956-149,944,793",inherited,homozygous,"1/4,000（though it affects one in 4,000, RP is clinically variable）",clinical features,http://dx.doi.org/10.1038/hgv.2016.36,https://hgv.figshare.com/genome_variation/894,,
missense,Distal arthrogryposis (DA),601680,NM_003282.3,TNNI2,191043,c.485>A,AGG，p.Arg162,AAG，Lys,11p15.5,1862717,inherited,heterozygous,N/A,clinical features and molecular diagnosis ,http://dx.doi.org/10.1038/hgv.2016.35,https://hgv.figshare.com/genome_variation/882,,
missense,Hartsfield syndrome (HS),615465,NM_023110,FGFR1,136350,c.758A>C,CAC，p.His253,CCC，Pro,8p11.23,38424687,de novo,heterozygous,only 10 HS-associated mutations have been reported thus far,clinical features and molecular diagnosis ,http://dx.doi.org/10.1038/hgv.2016.34,https://hgv.figshare.com/genome_variation/873,,
missense,Ehlers–Danlos syndrome (EDS),130000,NM_000393.3,COL5A2,120190,c.682G>A,GGA，p.Gly228,AGA，Arg,2q32.2,189951460,de novo,heterozygous,N/A,patient’s clinical presentation and family history,http://dx.doi.org/10.1038/hgv.2016.30,https://hgv.figshare.com/genome_variation/848,,
missense,Primary congenital glaucoma (PCG),231300,NM_000104.3,CYP1B1,601771,c.1103G>A,CGT，p.Arg368,CAT，His,2p21-22,38071251,inherited,homozygous,"1/10,000 （PCG occurs in approximately 1 in 10,000 live births, but the incidence varies widely between populations）",clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2016.21,https://hgv.figshare.com/genome_variation/829,,
missense,Primary congenital glaucoma (PCG),231300,NM_000104.3,CYP1B1,601771,c.241T>A,TAC，p.Tyr81,AAC，Asn,2p21-22,38075148,inherited,homozygous,"1/10,000 （PCG occurs in approximately 1 in 10,000 live births, but the incidence varies widely between populations）",clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2016.21,https://hgv.figshare.com/genome_variation/826,,
missense,Primary congenital glaucoma (PCG),231300,NM_000104.3,CYP1B1,601771,c.1331G>A,CGA，p.Arg444,CAA，Gln,2p21-22,38071023,inherited,homozygous,"1/10,000 （PCG occurs in approximately 1 in 10,000 live births, but the incidence varies widely between populations）",clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2016.21,https://hgv.figshare.com/genome_variation/823,,
missense,Primary congenital glaucoma (PCG),231300,NM_000104.3,CYP1B1,601771,c.685G>A,GAA，p.Glu229,AAA，Lys,2p21-22,38074704,inherited,homozygous,"1/10,000 （PCG occurs in approximately 1 in 10,000 live births, but the incidence varies widely between populations）",clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2016.21,https://hgv.figshare.com/genome_variation/820,,
missense,Primary congenital glaucoma (PCG),231300,NM_000104.3,CYP1B1,601771,c.1169G>A,CGC，p.Arg390,CAC，His,2p21-22,38071185,inherited,homozygous,"1/10,000 （PCG occurs in approximately 1 in 10,000 live births, but the incidence varies widely between populations）",clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2016.21,https://hgv.figshare.com/genome_variation/814,,
missense,Primary congenital glaucoma (PCG),231300,NM_000104.3,CYP1B1,601771,c.1300T>C,TGG，p.Trp434,CGG，Arg,2p21-22,38071054,inherited,homozygous,"1/10,000 （PCG occurs in approximately 1 in 10,000 live births, but the incidence varies widely between populations）",clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2016.21,https://hgv.figshare.com/genome_variation/808,,
missense,Primary congenital glaucoma (PCG),231300,NM_000104.3,CYP1B1,601771,c.1405C>T,CGG，p.Arg469,TGG，Trp,2p21-22,38070949,inherited,homozygous,"1/10,000 （PCG occurs in approximately 1 in 10,000 live births, but the incidence varies widely between populations）",clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2016.21,https://hgv.figshare.com/genome_variation/805,,
missense,Spondyloepiphyseal dysplasia (SED),604864,NM_001844.3,COL2A1,120140,c.1349G>C,GGC，p.Gly450,GCC，Ala,12q13.11,47987094,inherited,heterozygous,N/A,clinical features,http://dx.doi.org/10.1038/hgv.2016.7,https://hgv.figshare.com/genome_variation/787,,
missense,Waardenburg syndrome type 1 (WS1),193500,NM_181459,PAX3,606597,c.1107C>G,AGC，p.Ser369,AGG，Arg,2q35,222220206,uncertain,heterozygous,"1/42,000（Its prevalence is estimated to be 1/42,000）",clinical features,http://dx.doi.org/10.1038/hgv.2016.5,https://hgv.figshare.com/genome_variation/783,,
missense,Stickler syndrome (STL),604841,NM_001854.3,COL11A1,120280,c.4520G>A,GGT，p.Gly1507,GAT，Asp,1p21.1,102888757,uncertain,heterozygous,N/A,targeted resequencing；molecular diagnosis,http://dx.doi.org/10.1038/hgv.2016.3,https://hgv.figshare.com/genome_variation/780,,
missense,Syndrome of paraganglioma and somatostatinoma with polycythemia,N/A,NM_001430,EPAS1,603349,c.1589C>T,GCA，p.Ala530,GTA，Val,2p21-p16,46380261,de novo,heterozygous,N/A,peptide nucleic acid sequencing assay,http://dx.doi.org/10.1038/hgv.2015.53,https://hgv.figshare.com/genome_variation/765,,
missense,Syndrome of paraganglioma and somatostatinoma with polycythemia,N/A,NM_001430,EPAS1,603349,c.1588G>A,GCA，p.Ala530,ACA，Thr,2p21-p16,46380260,de novo,heterozygous,N/A,peptide nucleic acid sequencing assay,http://dx.doi.org/10.1038/hgv.2015.53,https://hgv.figshare.com/genome_variation/762,,
missense,Skin Pigmentation,227220,NM_000275.2,OCA2,611409,c.1441G>A,GCC，p.Ala481,ACC，Thr,15q,27983407,uncertain,heterozygous,N/A,clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2015.58,https://hgv.figshare.com/genome_variation/759,,
missense,Skin Pigmentation,227220,NM_000275.2,OCA2,611409,c.1844A>G,CAT，p.His615,CGT，Arg,15q,27951891,uncertain,homozygous,N/A,clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2015.58,https://hgv.figshare.com/genome_variation/756,,
missense,Infantile neuroaxonal dystrophy (INAD),256600,NM_003560.2,PLA2G6,603604,c.847G>A,GAC，p.Asp283,AAC，Asn,22q13.1,38531042,inherited,heterozygous,N/A,clinical symptoms and genetic analyses,http://dx.doi.org/10.1038/hgv.2015.48,https://hgv.figshare.com/genome_variation/735,,
missense,Legius syndrome,611431,NM 152594,SPRED1,152594,c.1024C>G,CCT，p.Pro422,CGT，Arg,15q13.2,38252086,de novo / inherited,heterozygous,N/A,clinical features,http://dx.doi.org/10.1038/hgv.2015.51,https://hgv.figshare.com/genome_variation/732,,
missense,"Epileptic encephalopathy, early infantile, 2",300672,XM_005274584.1,CDKL5,300203,c.533G>A,CGG，p.Arg178,CAG，Gln,Xp22.13,18602452,de novo,hemizygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2015.42,https://hgv.figshare.com/genome_variation/714,,
missense,Thoracic aortic aneurysms and/or dissections (TAAD),132900,NM_002474.2,MYH11,160745,c.3791T>C,CTG，p.Leu1264,CCG，Pro,16p13.11,15820772,inherited,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2015.28,https://hgv.figshare.com/genome_variation/668,,
missense,Severe congenital protein C (PC) deficiency,612304,NM_000312,PROC,612283,c.1015G>A,GTG，p.Val339,ATG，Met,2q14.3,15156,inherited,heterozygous,more than 200 mutations affecting PC have been reported worldwide；the frequency of heterozygous mutations in PROC in the Japanese population has previously been estimated at 1 in 700 ,earlier diagnosis with prenatal genetic testing；domino liver transplantation for the treatment,http://dx.doi.org/10.1038/hgv.2015.17,https://hgv.figshare.com/genome_variation/590,,
missense,Non-specific X-linked intellectual disability (XLID),N/A,NM_005120.2,MED12,300188,c.3067A>G,ATC，p.Ile1023,GTC，Val,Xq13.1,"70,338,406-70,362,304",inherited,hemizygous,number of the variants with <1% frequency in global population,clinical features,http://dx.doi.org/10.1038/hgv.2015.18,https://hgv.figshare.com/genome_variation/586,,
missense,Idiopathic congenital nystagmus (ICN),310700,NM_194277.2,FRMD7,90167,c.875T>C,CTC，p.Leu292,CCC，Pro,Xq26.2,131216421,uncertain,homozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2015.2,https://hgv.figshare.com/genome_variation/572,,
missense,Ichthyosis prematurity syndrome (IPS),608649,NM_005094.3,FATP4,604194,c.1529G>A,CGC，p.Arg510,CAC，His,9q34.11,"chr9: 131,117,743(hg19)",de novo,heterozygous,N/A,clinical features and genetic analyses,http://dx.doi.org/10.1038/hgv.2015.3,https://hgv.figshare.com/genome_variation/570,,
missense,Ichthyosis prematurity syndrome (IPS),608649,NM_005094.3,FATP4,604194,c.1208G>A,TGT，p.Cys403,TAT，Tyr,9q34.11,"chr9: 131,115,704(hg19)",de novo,heterozygous,N/A,clinical features and genetic analyses,http://dx.doi.org/10.1038/hgv.2015.3,https://hgv.figshare.com/genome_variation/568,,
missense,Late-onset Alzheimer's disease (AD),104300,NM_001031696.3,PLD3,615698,c.1430G>A,none，p.Asp477,none，Gly,19q13.2,40884037,uncertain,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.28,https://hgv.figshare.com/genome_variation/566,,
missense,Late-onset Alzheimer's disease (AD),104300,NM_001031696.3,PLD3,615698,c.1067G>A,none，p.Arg356,none，His,19q13.2,40882563,uncertain,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.28,https://hgv.figshare.com/genome_variation/558,,
missense,Late-onset Alzheimer's disease (AD),104300,NM_001031696.3,PLD3,615698,c.899G>A,none，p.Cys300,none，Tyr,19q13.2,40880475,uncertain,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.28,https://hgv.figshare.com/genome_variation/556,,
missense,Late-onset Alzheimer's disease (AD),104300,NM_001031696.3,PLD3,615698,c.851A>G,none，p.Asn284,none，Ser,19q13.2,40877752,uncertain,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.28,https://hgv.figshare.com/genome_variation/552,,
missense,Late-onset Alzheimer's disease (AD),104300,NM_001031696.3,PLD3,615698,c.779C>T,none，p.Ser260,none，Phe,19q13.2,40877680,uncertain,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.28,https://hgv.figshare.com/genome_variation/546,,
missense,Late-onset Alzheimer's disease (AD),104300,NM_001031696.3,PLD3,615698,c.761T>C,none，p.Leu254,none，Pro,19q13.2,40877662,uncertain,homozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.28,https://hgv.figshare.com/genome_variation/544,,
missense,Late-onset Alzheimer's disease (AD),104300,NM_001031696.3,PLD3,615698,c.694T>A,none，p.Val232,none，Met,19q13.2,40877595,uncertain,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.28,https://hgv.figshare.com/genome_variation/538,,
missense,Late-onset Alzheimer's disease (AD),104300,NM_001031696.3,PLD3,615698,c.689T>A,none，p.Leu230,none，His,19q13.2,40877590,uncertain,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.28,https://hgv.figshare.com/genome_variation/536,,
missense,Late-onset Alzheimer's disease (AD),600274,NM_001031696.3,PLD3,615698,c.665G>A,none，p.Arg222,none，His,19q13.2,40876131,uncertain,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.28,https://hgv.figshare.com/genome_variation/534,,
missense,Late-onset Alzheimer's disease (AD),104300,NM_001031696.3,PLD3,615698,c.226C>G,none，p.Pro76,none，Ala,19q13.2,40872803,uncertain,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.28,https://hgv.figshare.com/genome_variation/532,,
missense,Epilepsy of infancy with migrating focal seizures (EIFMS),614959,NM_020822.2,KCNT1,608167,c.1420C>T,CGC，p.Arg474,TGC，Cys,9q34.3,138660693,de novo,heterozygous,N/A,clinical features and genetic analyses,http://dx.doi.org/10.1038/hgv.2014.27,https://hgv.figshare.com/genome_variation/524,,
missense,Megalencephalic leukoencephalopathy with subcortical cysts (MLC),604004,NM_015166,MLC1,605908,c.824C>A,GCC，p.Ala275,GAC，Asp,22q13.33,50506932,inherited,heterozygous,MLC1 was first identified in 2001 and MLC1 mutations have been observed in 75% of patients with MLC,clinical features and genetic analyses,http://dx.doi.org/10.1038/hgv.2014.19,https://hgv.figshare.com/genome_variation/519,,
missense,Megalencephalic leukoencephalopathy with subcortical cysts (MLC),604004,NM_015166,MLC1,605908,c.278C>T,TCG，p.Ser93,TTG，Leu,22q13.33,50518816,inherited,heterozygous,MLC1 was first identified in 2001 and MLC1 mutations have been observed in 75% of patients with MLC,clinical features and genetic analyses,http://dx.doi.org/10.1038/hgv.2014.19,https://hgv.figshare.com/genome_variation/517,,
missense,Allan–Herndon–Dudley syndrome (AHDS) ,300523,NM_006517.4,SLC16A2,300095,c.449C>T,GCG，p.Ala150,GTG，Val,Xq13.2,73740843,inherited,hemizygous,N/A,clinical manifestations,http://dx.doi.org/10.1038/hgv.2014.10,https://hgv.figshare.com/genome_variation/511,,
missense,Allan–Herndon–Dudley syndrome (AHDS) ,300523,NM_006517.4,SLC16A2,300095,c.97T>C,TCT，p.Ser33,CCT，Pro,Xq13.2,73641569,inherited,hemizygous,N/A,clinical manifestations,http://dx.doi.org/10.1038/hgv.2014.10,https://hgv.figshare.com/genome_variation/509,,
missense,Combined Pituitary Hormone Deficiency (CPHD),N/A,NM_000216,KAL1,300836,c.1704C>A,CAC，p.His568,CAA，Gln,Xp22.31,8503770,uncertain,hemizygous,N/A,clinical features and genetic analyses,http://dx.doi.org/10.1038/hgv.2014.11,https://hgv.figshare.com/genome_variation/505,,
missense,Type II early-onset Alzheimer’s disease (AD),104300,NP_620579,HFE,613609,c.305G>A,none，p.Cys102,none，Tyr,6,26093141,inherited,heterozygous,N/A,genetic analyses,http://dx.doi.org/10.1038/hgv.2014.4,https://hgv.figshare.com/genome_variation/497,,
missense,Epidermolysis Bullosa Simplex (EBS) Koebner type,131900,NM_000424.3,KRT5,148040,c.974T>A,CTC，p.Leu325,CAC，His,12q13.13,52911492,inherited,heterozygous,"1/25,000-1/50,000（EBS is a rather rare genetic disorder with prevalence estimates of ~1 in 25,000–50,000 individuals）",genetic analyses,http://dx.doi.org/10.1038/hgv.2014.7,https://hgv.figshare.com/genome_variation/493,,
missense,Iris hypoplasia (IH),N/A,NM_153427.2,PITX2,601542,c.205C>T,CGC，p.Arg69,TGC，Cys,4q25,111542367G,inherited,heterozygous,N/A,whole-exome sequencing,http://dx.doi.org/10.1038/hgv.2014.5,https://hgv.figshare.com/genome_variation/21,,
missense,Alport syndrome (AS),203780,NM_000091.4,COL4A3,120070,c.3266G>A,GGC，p.Gly1089,GAC，Asp,2q36.3,228157962,uncertain,homozygous,N/A,clinical features and genetic analyses,http://dx.doi.org/10.1038/hgv.2014.6,https://hgv.figshare.com/genome_variation/13,,

